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ABSTRACT 
For a successful infection to occur, a virus must first penetrate host cell 
membranes to access intracellular sites of viral replication.  Currently the mechanism 
through which adenovirus, a non-enveloped, dsDNA virus, disrupts the endosomal 
membrane during cell entry is not well characterized.  
Recent studies suggest that adenovirus protein VI, which is released from the 
interior of the capsid during cell entry, has all of the in vitro membrane lytic activity of 
the virion. We found that protein VI binds membranes via an amino-terminal 80 residue 
α-helical domain. Critical to this interaction are conserved hydrophobic and basic lysine 
residues within this domain. Membrane disruption can occur by two different 
mechanisms: transmembrane pore formation or membrane fragmentation. Our studies 
indicate that protein VI fragments membranes by inducing membrane curvature stress.  
The observed mechanism for protein VI membrane disruption in vitro correlates 
with events during adenovirus endosomal escape.  Recombinant viruses with mutations in 
protein VI α-helical domain that either decrease hydrophobicity or reverse the positive 
charge of lysine residues have a defect in endosomal escape. These data suggest that 
electrostatic and hydrophobic interactions between protein VI and the endosomal 
membrane are important for adenovirus endosomal escape.  
  
xi 
 
Furthermore, the gross membrane reorganization by protein VI observed in vitro 
is consistent with our observations that adenovirus endosomal membrane rupture allows 
the interaction of a 30kD cytosolic protein, galectin-3 with exo-domains of endosomal 
transmembrane proteins. Galectin-3 recruitment to adenovirus-disrupted endosomal 
membranes can therefore serve as a marker for adenovirus membrane penetration. Using 
this marker, we have conclusively demonstrated that protein VI release from the capsid 
interior precedes endosomal membrane rupture. Thus, use of galectin-3 to detect 
adenovirus rupture of endosomal membranes by microscopy will likely contribute greatly 
to our further understanding of intracellular viral trafficking during cell entry. 
The work presented in this dissertation provides significant insight into the 
mechanism used by adenovirus to penetrate cell membranes during entry.  Furthermore, 
since endosomal disruption is necessary for this virus to activate the innate immune 
response, these studies also have important implications for understanding how the 
immune system recognizes adenovirus infection. 
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CHAPTER I 
INTRODUCTION 
COMPARISON OF ENVELOPED AND NONENVELOPED VIRUS ENTRY 
A virus is a microscopic infectious agent that can only replicate within a host cell. 
Therefore, to establish a productive infection, viruses have to deliver their genetic 
material into a cell. To do so these agents must first bind a target cell and permeabilize its 
membrane. Viruses have developed unique strategies of disrupting cellular membranes 
depending on the virus structure (Tsai 2007). One important structural feature is the 
presence of a lipid bilayer surrounding the virus. Enveloped viruses are viruses that have 
this membrane layer, while viruses that lack this characteristic are classified as 
nonenveloped viruses. 
The presence or absence of the lipid bilayer dictates how a virus penetrates 
cellular membranes. Enveloped viruses induce the fusion of the viral envelope with the 
cellular membrane, while nonenveloped viruses must lyse the limiting cell membrane 
(Poranen, Daugelavicius et al. 2002; Smith and Helenius 2004). Although the mechanism 
of membrane penetrations (fusion vs membrane lysis) is different, the series of events 
that lead to this process is similar between the two virus groups. 
One such similarity is that the fusion peptide or the membrane disrupting factor is buried 
within the virion, and is only exposed at the site of membrane penetration. 
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Enveloped virions are decorated with glycoproteins protruding from the viral 
bilayer, and they can function in cell binding as well as membrane fusion (Takimoto, 
Taylor et al. 2002). Membrane fusion is mediated by a fusion peptide often buried within 
these glycoproteins. The peptide is exposed only when a conformational change occurs in 
the glycoprotein (Harrison 2008). The triggering event that mediates this process dictates 
the site of membrane penetration. For example, HIV-1 fusion occurs at the cell surface 
and is triggered by the sequential interaction of the viral glycoprotein with a cellular 
receptor and a co-receptor (Harrison 2005). Other enveloped viruses such as influenza are 
first taken up by endocytosis, and the low-pH in the endosome triggers a conformational 
change in the hemagglutinin (HA) protein that exposes the fusion peptide (Bullough, 
Hughson et al. 1994). This peptide then induces fusion of the viral membrane with the 
endosomal membrane (Han, Bushweller et al. 2001; Borrego-Diaz, Peeples et al. 2003).   
  Similar to the enveloped virus glycoproteins, nonenveloped viruses have outer-
layer capsid proteins that can serve in membrane binding and membrane penetration. 
Membrane penetration is mediated either by a membrane lytic factor that is released from 
the capsid, or by exposure of a hydrophobic moiety in the capsid proteins (Tsai 2007). 
These factors are buried within the capsid, and are exposed at the site of membrane 
penetration by triggering events such as receptor interaction, a decrease in pH, or cellular 
proteases (Fricks and Hogle 1990; Ebert, Deussing et al. 2002; Wiethoff, Wodrich et al. 
2005). Enveloped virus membrane fusion has been studied in great detail, and as a result 
the different steps in this process are well characterized (Poranen, Daugelavicius et al. 
2002; Harrison 2008). However, the molecular mechanism of membrane penetration by 
nonenveloped viruses is still poorly understood. 
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NONENVELOPED VIRUS ENTRY 
Nonenveloped virus entry can be divided into four steps: traffic to the site of 
membrane penetration, exposure of a membrane lytic factor, membrane disruption, and 
virion translocation across this membrane. The cellular conditions that trigger the 
membrane lytic protein to be exposed, as well as the identity of many of these proteins 
are now known. However the molecular mechanism of membrane disruption is not well 
characterized. The work described in this dissertation has shed some light on the process 
used by a nonenveloped virus to disrupt membranes. 
 Traffic to site of membrane penetration 
The first step in successfully permeabilizing cellular membranes is virus 
trafficking to the appropriate site of membrane penetration. For some viruses these sites 
are cellular organelles such as the endosome or the ER. There are two main pathways a 
virus can use to reach these sites: clathrin or caveolae mediated endocytosis (Marsh and 
Helenius 2006).  These two pathways differ in the mechanism used to initiate endocytosis 
as well as the factors involved. Clathrin dependent endocytosis is mediated by the protein 
clathrin and occurs in clathrin coated pits on the plasma membrane (Reider and 
Wendland ; Meier and Greber 2004). On the other hand, caveolae mediated endocytosis 
occurs in membrane microdomains rich in cholesterol, glycosphingolipids and the 
cholesterol binding protein caveolin (Li, Song et al. 1996). The best studied viruses that 
use caveolae dependent endocytosis belong to the  polyomavirus family and include 
SV40, mouse polyomavirus, and the human pathogens BK and JC viruses (Norkin, 
Anderson et al. 2002).  Similar to many viruses that use this pathway, polyomaviruses 
use different gangliosides as receptors. Receptor binding triggers caveolae mediated 
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endocytosis and subsequent transport to the ER, where these viruses are thought to cross 
the ER membrane to the cytoplasm (Qian and Tsai ; Gilbert and Benjamin 2004). On the 
other hand, canine parvovirus binds the transferrin receptor, and is internalized via 
clathrin mediated endocytosis. This virus is then transported to the recycling endosome, 
however the site of membrane penetration is not clear (Suikkanen, Antila et al. 2003).  
Release of the membrane lytic factor 
Upon reaching the membrane penetration site, the viral capsid protein of 
nonenveloped viruses must undergo a series of structural rearrangements to lyse the 
limiting membrane. These rearrangements result in release of a membrane lytic factor or 
the exposure of a hydrophobic moiety that mediates membrane lysis. The cellular factors 
that trigger these conformational changes differ depending on the site of membrane 
penetrations. For instance, poliovirus interaction with its receptor PVR on the target cell 
initiates the membrane penetration process. Receptor binding induces a conformational 
change in the virion that exposes the viral protein 4 (VP4) and the N terminus of the virus 
protein 1 (VP1) (Fricks and Hogle 1990). The myristolated VP4 and N terminus of VP1 
insert into the membrane to form a transmembrane pore (Tosteson and Chow 1997).  
Other viruses use cellular proteases to activate the virus into the membrane 
disrupting intermediate. During reovirus infection the outermost capsid protein σ3 is 
digested by the endolysosomal proteases cathepsin L and cathepsin B exposing the capsid 
protein μ1(Nibert and Fields 1992; Danthi, Guglielmi et al. 2010). An autocatalytic event 
then occurs resulting in the release of a myristolated N terminal fragment of μ1, μ1N, 
which has lytic activity (Zhang, Chandran et al. 2006).  Other cellular proteases such as 
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furin and trypsin have been implicated in activating viruses such as papillomavirus and 
rotavirus respectively (Estes, Graham et al. 1981; Richards, Lowy et al. 2006). 
Similar to their enveloped counterpart, where low pH induces membrane fusion, a drop in 
pH also triggers nonenveloped virus membrane penetration. The parvovirus minute virus 
of mice (MVM) deploys the lipolytic enzyme phospholipase A2 (PLA2) to lyse 
membranes (Farr, Zhang et al. 2005). This enzyme is located at the N terminus of the 
coat protein VP1 and studies suggest that a decrease in pH is important for PLA2 activity 
(Suikkanen, Antila et al. 2003; Mani, Baltzer et al. 2006). 
Membrane penetration: pore formation and membrane fragmentation 
Once the virus releases its membrane disrupting protein or virus intermediate, the 
next step is the actual lysis process. Although the steps that lead to nonenveloped virus 
membrane disruption are slowly being understood, the mechanism of membrane lysis is 
poorly characterized. Membrane disruption by antimicrobial peptides on the other hand is 
well understood. These peptides are small molecular weight proteins that have a broad 
spectrum antimicrobial activity against bacteria and viruses (Boman 1995). In most cases 
their mode of action appears to be direct lysis of the pathogenic cell membrane (Shai 
1999). This is possible due to the amphipathic α- helix structure they acquire upon 
membrane binding (Dathe and Wieprecht 1999). This structure is characterized by the 
partitioning of the hydrophobic and hydrophilic residues on opposite sides of the helix. 
There are two distinct mechanisms of membrane disruption by antimicrobial peptides: a 
detergent-like membrane fragmentation and the formation of transmembrane pores (Shai 
2002).  
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A key difference between these two different mechanisms is the orientation of the 
peptide on the lipid bilayer. To form a transmembrane pore the amphipathic α-helical 
peptide must traverse the lipid bilayer. The hydrophobic surface of the helix interacts 
with the hydrophobic core of the membrane and the hydrophilic surface points inward 
lining an aqueous pore (Ehrenstein and Lecar 1977). On the other hand, peptides that 
fragment membranes bind the lipid bilayer with a parallel orientation by electrostatically 
interacting with negatively charged lipid head groups (Pouny, Rapaport et al. 1992; 
Gazit, Boman et al. 1995). Surface membrane binding results in the induction of a 
membrane curvature stress that ultimately fragments the membranes (Brender, Durr et al. 
2007). Experimentally discerning between these two different mechanisms of membrane 
disruption can be made by monitoring the release of different size dyes from model 
membranes. For example, the mechanism of membrane disruption by the antimicrobial 
peptide melittin depends on its orientation on the lipid bilayer (Ladokhin and White 
2001). In conditions where melittin traverses the lipid bilayer, this peptide forms size 
selective pores, as determined by its ability to release a 4kD dextran but not a 50kD 
dextran from model membranes. However, when melittin has a parallel membrane 
orientation, it fragments the lipid bilayer resulting in the release of both dextrans from 
liposomes.  
These two mechanisms of membrane disruption that have been demonstrated for 
antimicrobial peptides are also observed with virus lytic peptides. Ivanovic et al has 
shown that the membrane lytic peptide of reovirus μ1N forms size-selective pores in 
membranes. This peptide is generated and released from the capsid as a result of 
autocatalytic event of capsid protein σ1. When added to resealed red blood cell ghosts 
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that are loaded with fluorescently labeled dextrans of different sizes, μ1N facilitates the 
release of 3kD and 10kD but not 40kD dextrans. These data suggest that reovirus μ1N 
forms pores with a 4-9nm diameter (Agosto, Ivanovic et al. 2006; Ivanovic, Agosto et al. 
2008). Poliovirus also penetrates membranes by forming a transmembrane pore. Binding 
its receptor on the target cell triggers a conformational change that exposes the N 
terminus of the capsid protein VP1 and the myristolated autocleavage peptide VP4 
(Fricks and Hogle 1990). Interaction of these proteins with the membranes results in the 
formation of an ion permeable channel, through which the viral genomic RNA can be 
translocated to the cytoplasm (Tosteson and Chow 1997). 
A different mechanism is used by the parvovirus MVM. As mentioned earlier, the 
viral capsid protein VP1 contains at its N terminus a PLA2 enzymatic core (Zadori, 
Szelei et al. 2001; Dorsch, Liebisch et al. 2002). This enzyme is a  membrane lytic factor 
which facilitates MVM endosomal escape (Farr, Zhang et al. 2005). Cellular PLA2 
cleaves phospholipid molecules to generated free fatty acid and a lysophospholipid (a 
lipid with one acyl tail) (Brown, Chambers et al. 2003). This activity has been shown to 
result in membrane tubule formation with increased membrane curvature (de Figueiredo, 
Drecktrah et al. 1998). As mentioned earlier, the induction of membrane curvature stress 
results in membrane fragmentation, although this process has not been demonstrated with 
MVM.  
Virus translocating across the limiting membrane 
Once the limiting membrane has been permeabilized, the next step is the physical 
transport of the virus across the limiting membrane. Until now this event has not been 
directly demonstrated. Membrane penetration has been suggested based on evidence that 
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viruses, such as adenovirus, can result in the cytoplasmic translocation of cointernalized 
proteins or DNA (FitzGerald, Padmanabhan et al. 1983; Yoshimura, Rosenfeld et al. 
1993; Seth, Rosenfeld et al. 1994) Additionally, electron microscopy studies have shown 
nonenveloped viruses in the cytoplasm (Imelli, Ruzsics et al. 2009). These results 
however do not directly demonstrate the actual membrane transport event. The rapid 
speed by which this process occurs makes it difficult to capture this event in fixed cells. 
Work presented in this dissertation has identified an assay that can be used to directly 
monitor membrane disruption by nonenveloped viruses.  
 
GALECTIN 3 AS A MARKER FOR VACUOLE LYSIS 
Similar to viruses, bacteria disrupt vacuolar membranes to infect cells. Compared 
to other steps in the bacterial life cycle, vacuole lysis is not well understood, due to the 
lack of markers associated with disrupted phagosomes. Paz et al has identified a marker 
for ruptured phagosomes and this marker is the protein Galectin 3 (Gal-3). 
Gal-3 is a member of the galectin family, a conserved family of lectins. These 
proteins are cytosolic and contain consensus sequences in their carbohydrate binding 
domain (CRD) which have an affinity for β-galactoside containing glycoconjugates 
(Hughes 1997). The structure of Gal-3 is unique among the different galectins and it is 
composed of one CRD at the C terminus and a N-terminal, non-lectin domain consisting 
of multiple repeats of a peptide sequence rich in proline, glycine, and tyrosine (PGY 
repeats) (Albrandt, Orida et al. 1987; Cherayil, Weiner et al. 1989). Gal-3 is found in 
many different tissues, expressed mainly in epithelial and myeloid cells, and has a variety 
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of different biological functions such as a role in inflammation, cell adhesion and 
cancer(Liu and Rabinovich 2005; Rabinovich and Toscano 2009).  
In addition to the above mentioned cellular functions, Paz et al has shown that 
Gal-3 can also serve as a marker for ruptured phagosomes. Using immunofluorescence 
microscopy this group observed Gal-3 punctate structures accumulating around the 
bacteria in Shigella infection. These structures were not formed in cells infected with a 
mutant Shigella that fails to lyse the phagosome.  Furthermore, Gal-3 puncta were 
observed by electron microscopy to bind membrane remnants and not the bacteria. Gal-3 
labeling disrupted vacuoles was not specific to Shigella infection, since punctuate 
structures were seen in phagosomes ruptured by other bacteria. The cytosolic Gal-3 labels 
disrupted membranes by binding N- linked glycans found on the plasma membrane when 
these are exposed following membrane lysis (Fig. 1). Taken together these data suggest 
that Gal-3 can serve as a marker for vacuole lysis, and could potential be used to monitor 
membrane disruption by a nonenveloped virus. 
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Fig. 1. Galectin-3 a marker for vacuole lysis. 
Galectin 3 is a cytosolic protein that binds N-linked glycans. These glycans are present 
on the cell membrane, and are exposed to the cytosol only after vacuole lysis. Therefore, 
when a vacuole is lysed galectin-3 can bind N-linked glycans, and this binding can be 
visualized by immunofluorescence microscopy as punctuate staining. 
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ADENOVIRUS AS A MODEL SYSTEM FOR STUDYING NONENVELOPED 
VIRUS ENTRY 
 
Adenovirus is an excellent model system to study nonenveloped virus entry. The 
adenovirus structure is well characterized, and the role of various cellular and viral 
proteins in adenovirus cell entry is known. In addition, a number of the viral capsid 
proteins can be produced as recombinant proteins in bacterial expression systems, 
allowing analysis of their function independent of the intact virion. Since many features 
of adenovirus cell entry are common to the entry mechanisms of other nonenveloped 
viruses, these studies will shed significant light on how these viruses enter cells.  
  Adenoviruses and disease 
Human adenoviruses (Ads) were initially isolated more than 50 years ago by 
Hilleman and Rowe from patients with acute respiratory disease (Hilleman and Werner 
1954, Rowe et al 1955). Currently there are at least 56 serotypes that are grouped in 
seven different species (A-G). In addition to acute respiratory syndrome, these viruses 
can also cause conjunctivitis, keratoconjunctivitis, and acute gastroenteritis. Most Ad 
infections occur early in life, and by the age of 10 most individuals have been infected 
with at least one serotype. In healthy individuals Ad infection is self-limited; however it 
can cause serious complications in immunocompromised individuals (Hierholzer 1992; 
Leen and Rooney 2005). Despite its association with human disease, Ad has also served 
as an important tool in understanding a number of biological processes (Chow, Gelinas et 
al. 1977; Berget, Moore et al. 2000). Furthermore Ad vectors are easy to purify, they 
allow for packaging of large genes and they have a wide tissue tropism, making them 
good candidates as vectors for gene therapy and vaccine development (Harvey, 
Kamphuis et al. 2002).  
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  Adenovirus structure 
Ad is among the largest non-enveloped viruses (90nm in diameter). Its structure is 
made up of an outer capsid, with icosahedral symmetry, surrounding the nucleocapsid 
core (Fig. 2). The outershell is primarily formed by 240 trimers of the capsid protein 
hexon, which forms the twenty facets of the icosahedrons (van Oostrum, Smith et al. 
1987).  Located at each of the 12 vertices is the penton complex, consisting of the 
homopentameric penton base non-covalently associated with the homotrimeric fiber 
protein (van Oostrum and Burnett 1985; Stewart, Fuller et al. 1993). The capsid is 
stabilized by four minor capsid proteins (IIIa, VI, IX and VIII) which act as cement 
proteins by interacting with each other as well as hexon and core proteins (Stewart, Fuller 
et al. 1993; Saban, Silvestry et al. 2006) The viral core contains the 36 kB double 
stranded DNA genome covalently bound to a terminal protein (TP) (Philipson 1995). 
This genome is also associated with the core proteins V, VII and Mu. In addition to the 
11 structural proteins, the Ad capsid also contains a viral cysteine protease (23k) which is 
important for virus maturation (Cotten and Weber 1995).  
Adenovirus life cycle 
Ad infection begins with a high affinity interaction between the fiber protein and 
the coxsackie-adenovirus receptor (CAR) on target cells (Bergelson, Cunningham et al. 
1997) (Fig. 3). A second lower affinity interaction between penton base and αv integrins 
triggers clathrin mediated endocytosis (Wickham, Mathias et al. 1993). Upon endosome 
acidification the capsid partially disassembles and pVI is released from the capsid interior  
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Fig. 2. Adenovirus structure 
Adenovirus is a nonenveloped virus with icosahedral symmetry. The viral capsid is made 
up of the major proteins hexon, penton base and fiber as well as the minor capsid proteins 
(III, IX, VI, VIII) The virus core is made up of proteins V, VII, mu and surrounds the 
dsDNA genome. The viral terminal protein (TP) is covalently bound to the genome  
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(Greber, Willetts et al. 1993). This protein has all of the in vitro membrane lytic activity 
of the virion (Wiethoff, Wodrich et al. 2005), suggesting that pVI disrupts endosomal 
membranes, allowing the virus to escape to the cytosol. The partially disassembled capsid 
then migrates on microtubules to the nucleus, docks at the nuclear pore, and releases its 
DNA genome into the nucleus, where viral transcription and DNA replication occurs 
(Greber, Willetts et al. 1993; Trotman, Mosberger et al. 2001).  In addition to mediating 
Ad endosomal escape, pVI is also necessary for virus assembly. Ad assembly occurs in 
the nucleus, and requires pVI to bring hexon into the nucleus (Wodrich, Guan et al. 
2003). Immature non-infectious virions are formed in the nucleus, and they contain the 
precursor forms of several structural proteins. These immature viruses become infectious 
when pVI activates the viral 23K protease, to cleave these structural proteins into their 
mature form (Anderson, Baum et al. 1973; Mangel, McGrath et al. 1993). The mature 
virions are then released usually upon destruction of the cell through mechanisms that are 
not well characterized (Jiang, White et al.). 
 
ADENOVIRUS CELL ENTRY 
Entry of human Ad into cells is a stepwise process. It can be divided into three 
separate events: attachment to the target cell, internalization, and endosomal escape (Fig. 
3). These events are mediated by different viral proteins. Attachment occurs when the 
viral fiber protein binds its cellular receptor. An interaction between penton base and 
cellular integrins induce virus internalization via clathrin-mediated endocytosis. Finally 
the virus disrupts the endosomal membrane to gain access to the cytoplasm using protein 
VI. 
15 
 
 
 
 
 
 
 
Fig. 3. Adenovirus cell entry  
Ad binds its target cell via a high affinity interaction between the fiber protein and the 
CAR receptor. A second interaction between penton base and αv integrins triggers 
clathrin mediated endocytosis. Upon acidification of the endosome, the virus partially 
disassembles.  Protein VI is released from the capsid interior and disrupts the endosomal 
membrane facilitating Ad cytosolic translocation.  
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Adenovirus cell binding and internalization 
Ad cell entry begins with the virus binding its target cells, followed by virus 
internalization via clathrin mediated endocytosis. Early studies by Silver and Anderson 
(1988) have shown that Ad2 binds but does not enter certain cells, suggesting that 
attachment and internalization are two separate events. These observations were 
confirmed by Wickham et al (1993) who showed that Ad2 entry into cells occurs upon 
engagement of αv integrins. 
Ad  cell attachment is mediated by the viral fiber protein. This fiber protein is a 
homotrimer, which projects from the virus surface at each of the 12 vertices. Each 
subunit of the fiber protein is made up of three domains: the amino terminal tail which 
associates with the viral penton base,(Devaux, Adrian et al. 1990), the shaft, and the knob 
which interacts with the cellular receptor  (Philipson, Lonberg-Holm et al. 1968; Kirby, 
Davison et al. 2000)  There are two main receptors that the fiber protein has been shown 
to bind: the coxsackie-adenovirus receptor (CAR) and CD46. 
CAR is a 46-kDa transmembrane protein that was initially identified as a cellular 
receptor for coxsackie B viruses, Ad2 and Ad5. In addition to subgroup C Ad fibers, 
CAR binds fibers from subgroups A,D,E, F (Roelvink, Lizonova et al. 1998). Since its 
identification as a receptor for Ad2 and Ad5 this protein has been studied extensively. 
The normal cellular function of CAR is to mediate cell adhesion by forming homodimers 
(Honda, Saitoh et al. 2000; Philipson and Pettersson 2004). CAR is an immunoglobulin 
superfamily protein with two extracellular Ig-like domains  (related to the 
immunoglobulin V (IgV) and  C2 (IgC2) domain folds), a single membrane-spanning 
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sequence, and a significant cytoplasmic domain. The CAR region necessary for binding 
the fiber protein is the N terminal IgV-related CAR domain (D1). (Freimuth et al  1999) 
In humans CAR is expressed in a variety of different tissues, with the exception of 
muscle cells and B and T cells (Freimuth, Philipson et al. 2008). Important to Ad 
infection of the respiratory tract is the fact that CAR is expressed in respiratory epithelial 
cells, and it is localized to the tight junctions and the basolateral side of polarized 
epithelial cells (Cohen, Shieh et al. 2001). Thus CAR is not accessible to Ad, which 
infects from the apical side. It has been suggested that infection starts in nonpolarized 
cells that express CAR on the apical side, or in pre-existing lesions in the epithelium 
(Meier and Greber 2003). Walters et al (Walters, Freimuth et al. 2002) have shown that 
before cell lysis, an excess of fiber protein is released basolaterally from infected cells. 
The affinity of fiber interaction with CAR is greater than the CAR- CAR interaction in 
the tight junctions. Therefore binding of CAR to the excess fiber can disrupt the junctions 
between the epithelial cells and promote viral release to the airway lumen, increasing 
viral spread. 
While CAR is the attachment receptor for most Ad subgroups, the fiber protein of 
subgroup B viruses binds a different cell surface receptor. Several groups have identified 
the membrane cofactor CD46 to be this receptor (Gaggar, Shayakhmetov et al. 2003; 
Segerman, Atkinson et al. 2003; Marttila, Persson et al. 2005). CD46 belongs to a family 
of proteins that regulate complement activation. This protein is expressed on all cell types 
except erythrocytes and its biological role is to prevent complement activation by 
autologous tissue (Post, Liszewski et al. 1991; Hsu, Dorig et al. 1997). The structure of 
this protein consists of an extracellular region that contains four copies of a structural 
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motif named the short consensus repeat (SCR I-IV). The SCRs are then connected to a 
linker rich in serines, threonines and prolines (STP) followed by a single membrane-
spanning domain and the C terminal cytoplasmic tail (Hsu, Dorig et al. 1997). The fiber 
protein of subgroup B viruses binds CD46 by interacting with SCRI and SCRII (Fleischli, 
Verhaagh et al. 2005; Persson, Reiter et al. 2007).  
While virus attachment to cells is mediated by an interaction between fiber 
protein and the cellular receptors CAR or CD46, virus internalization requires a second 
interaction with a separate cellular receptor.  Wang X et al (1999) have shown that the 
cytoplasmic tail of CAR is not required for virus infection, suggesting that signalling 
through a different receptor is needed for internalization. Additionally in the late 1950 
studies have shown that a viral protein called “the toxic factor” is release from infected 
cells, causing cells to detach from glass or plastic surfaces (Everett and Ginsberg 1958; 
Pereira 1958) This “toxic factor” is in fact the viral penton base which Wickham et al 
(1993) has shown to bind av integrins and mediate virus internalization. The cell 
detachment observed in infected cells can be explained by integrins binding released 
penton base instead of binding the extracellular matrix.  
The adenoviral penton base is a 400 kD coat protein that binds noncovalently to 
the fiber protein, forming a penton complex at each of the 12 vertices of the Ad virion. 
Electron microscopy studies have shown that the N terminal domain of fiber inserts into 
the central cavity of the penton base  (Stewart, Burnett et al. 1991; Fabry, Rosa-Calatrava 
et al. 2005). The penton base is then made up of five identical subunits that each contain 
an Arg-Gly-Asp (RGD) motif (Neumann, Chroboczek et al. 1988). This motif is 
important for binding integrins (Cheresh and Spiro 1987).  
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Integrins are heterodimeric transmembrane proteins composed of an α subunit and 
a β subunit. There are 20 different members of the integrin family and many can bind 
RGD motifs in host extracellular matrix proteins (Campbell and Humphries).  Integrin 
interaction with these proteins results in signalling and mediate important cellular 
functions such as cell attachment, migration and differentiation (Hynes 2002). Binding of 
the adenoviral penton base to αv integrins results in activation of a signalling cascade that 
induces clathrin mediated endocytosis. Interfering with proteins that are involved in this 
process prevents Ad infection (Varga, Weibull et al. 1991; Rauma, Tuukkanen et al. 
1999).  In addition, EM studies have detected incoming virions in clathrin coated pits 
(Chardonnet and Dales 1970; Svensson 1985). 
Adenovirus uncoating 
Virus internalization triggers a process called viral uncoating, in which the protein 
coat that protects the Ad genome from the extracellular environment is partially shed. Ad 
uncoating has therefore been measured as an increase in the accessibility of the viral 
DNA to DNAse or DNA sensitive dyes. The current model based on studies with 
subgroup C and B viruses suggests that uncoating occurs in discrete steps. As a 
consequence of virus engaging its cellular receptor, the fiber protein is shed at the cell 
surface (Nakano, Boucke et al. 2000). Upon acidification of the endosomes, additional 
viral proteins such as the internal proteins IIIa, VIII and protein VI, and some of the 
hexon proteins are released (Greber, Willetts et al. 1993). This process is required for 
endosomal escape since a naked capsid containing the DNA, core proteins, and some 
hexon is translocated into the cytoplasm (Greber, Willetts et al. 1993). 
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  Further evidence supporting a role for virus uncoating in endosomal lysis has 
been obtained from analysis of a temperature sensitive mutant Ad type 2 (Ad2ts1). When 
grown at the non-permissive temperature this virus fails to uncoat (Weber 1976; Mirza 
and Weber 1979). This defect is due to a point mutation (P137L) in the 23K protease. 
This mutation is linked to a decrease in protease incorporation into the virion (Rancourt, 
Keyvani-Amineh et al. 1995). The 23K protease functions inside the virion to cleave six 
structural proteins into their mature form (Webster, Russell et al. 1989; McGrath, Abola 
et al. 1996). A failure to incorporate the protease into the virion results in an immature 
virus, with increased stability (Silvestry, Lindert et al. 2009). Although Ad2ts1 can bind 
the CAR receptor and undergo internalization, it fails to escape the endosome, and is 
degraded in the lysosome (Greber, Webster et al. 1996) These observations suggest a link 
between capsid disassembly and endosomal lysis.  
 Adenovirus endosomal escape 
Adenovirus endosomal disruption has been demonstrated by the release of 
cointernalized molecules such as proteins or nucleic acids into the cytoplasm (FitzGerald, 
Padmanabhan et al. 1983; Yoshimura, Rosenfeld et al. 1993). Furthermore, Ad can 
induce the release of fluorescent dyes from liposomes  (Blumenthal, Seth et al. 1986). 
These early studies have also shown that the membrane lytic activity of Ad is pH 
dependent, since agents that block endosomal acidification inhibit endosomal escape, but 
not virus internalization (Greber, Willetts et al. 1993). Membrane penetration also 
required capsid disassembly, however the membrane lytic factor was not known.    
Wiethoff et al. (2005) set out to determine the role of Ad capsid disassembly in 
endosomal lysis, and while doing so this group identified the  Ad membrane lytic factor. 
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 To determine the capsid protein mediating membrane disruption, the capsid was 
disassembled and the dissociated proteins were separated from the partially uncoated 
virus using a step gradient. Testing the membrane lytic activity of the different fractions 
revealed that the released proteins contained all of the membrane lytic activity of the 
virus. This lytic activity was abrogated when pVI was immunodepleted from the 
dissociated protein fractions. Furthermore a recombinant pVI could also disrupt 
membranes. Taken together these data suggest that pVI is the Ad membrane lytic factor.  
Protein VI is a structural protein with a variety of different functions in the Ad life 
cycle. Electron microscopy studies propose that pVI is located within the cavity of all 
hexon trimers in the virion (Saban, Silvestry et al. 2006). This protein is suggested to be a 
trimer of dimers, with 360 monomers per virion (Stewart, Fuller et al. 1993). Upon virus 
maturation the viral protease cleaves pVI to the mature form. Although the crystal 
structure of pVI is not known, the N terminus of the mature pVI is predicted to be a four-
helix bundle, with the rest of the protein predicted to be mainly unstructured. The first 
helix in this bundle is predicted to be an amphipathic α-helix (residues 36-53) (Fig 4A). 
This helix is important for the in vitro membrane lytic activity of pVI. Wiethoff et al 
(2005) has shown that a recombinant pVI that lacks this helix has decreased membrane 
lytic activity compared to full length pVI. This group has further shown that while Ad 
partial disassembly and release of pVI is pH dependent, the membrane lytic activity of 
pVI is pH independent. However the mechanism of pVI membrane lytic activity is not 
known. 
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CHAPTER II 
MATERIALS AND EXPERIMENTAL METHODS 
CELL LINES. 
 Tissue culture reagents were obtained from Mediatch and HyClone. HeLa cells and 
293β5 cells were obtained from ATCC and maintained in Dulbecco modified Eagle 
medium (DMEM) supplemented with 10% fetal bovine
 
serum (FBS), 100 IU/ml 
penicillin, 1 mg/ml streptomycin, 0.25 μg/ml amphotericin B, non-essential amino acids, 
1 mM sodium pyruvate, 10 mM HEPES buffer and 2 mM glutamine.  
 
VIRUSES 
The temperature sensitive mutant ts1(Weber 1976), and Ad5-GFP (Wiethoff, 
Wodrich et al. 2005), an E1/E3-deleted adenovirus encoding EGFP under the control of a 
CMV promoter, were propagated in 293β5 cells. Viruses were purified from cellular 
lysates by double banding in cesium chloride gradients and dyalized in 40 mM Tris, 150 
mM NaCl, 10% glycerol, and 1 mM MgCl2 (pH 8.2). For these studies, the ts1 virus was 
propagated at the nonpermissive temperature of 39.5 °C. (Cotten and Weber 1995), ). 
Viral concentrations were determined by Bradford assay (Bio-Rad Laboratories, Inc.) and 
aliquots
 
were flash frozen in liquid nitrogen and stored at –80°C. Reovirus strain T3D 
was derived from lab stocks which were twice plaque purified. Virus was propagated on 
L929 cells and purified by cesium chloride density gradient centrifugation as previously 
described (Furlong, Nibert et al. 1988) 
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Generating the K45E virus 
The K45E mutation was introduced into the Ad genome using a two step BAC 
recombination protocol (Tischer, von Einem et al. 2006)  performed in GS1783 E. coli 
cells (a gift from GS lab). This strain encodes the lambda Red recombination proteins, 
and the I-SceI enzyme under inducible promoters (Tischer, Smith et al.) In the first step a 
kanamycin cassette was inserted in pVI, by a recombination between pAd5-BAC and the 
product of PCR amplifying kanamycin from the pEPKan-S2 plasmid (a gift from GS lab) 
using the following primers: 5’ATGAGCGGTGGCGCCTTCAGCTGGGGCTCG 
CTGTGGAGCGGCaTTGAAAATTTCGGTTCCACC AGGATGACGACGATA 
AGTAGGG3’and 5’GTTCCAGGCCTTGCTGCCATAGTTCTTAACGGTG 
GAACCGAAATTTTCAATGCCGCTCCACAGCAACCAATTAACCAATTCTGATT
AG 3’.The sequence homologous to pEPKan-S2 is underlined. The kanamycin cassette 
was replaced with a K45E PCR product through a second recombination event. The PCR 
product was generated by amplifying form pVIhis-K45E using the primers 
5’ATGAGCGGTGGCGCCTTCAGCTGGGGCTCGCTGTGGAGCGGCATTGAAA 
ATTTCGGTTCCACC AGGATGACGACGATAAGTAGGG 3’ and 5’GTTCCAGGC 
CTTGCTGCCATAGTTCTTAACGGTGGAACCGAAATTTTCAATGCCG 
CTCCACAGCAACCAATTAACCAATTCTGATTAG 3’ The altered sequence is in 
bold. A third recombination between pAd5-BAC-K45E and PmeI linearized pADtrack 
introduced a GFP cassette in the K45E viral genome (pAd5-GFP- K45E). The mutant 
virus was then generated as described above. 
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Generating the K45EK52E virus 
The K45EK52E mutation was introduced into pVI in the Ad genome using 
recombineering as previously described (Warming, Costantino et al. 2005) The mutant 
pVI was amplified from the pVIhis-K45EK52E plasmid using the following primers: 
pVIfor 5’ AGTCTGGACTCTCACG 3’and pVIrev 5’ GGCGACATGGACGC 3’ The 
PCR product was incorporated into the Ad5 genome via lambda Red recombination in 
bacteria harboring pAd5-GFP ΔpVIgalK. This vector contains pVI replaced with the 
galactokinase (galK) cassette of pGalK, and was generated by lambda Red 
recombinantion between pAd5-GFP and the product of PCR amplifying galK using the 
following primers:  pVIgalK for 5’ GACATCAACTTTGCGTCTCTGGCCCCGC 
GACACGGCTCGCCCTGTTGACAATTAATCATCGGCA 3’ and pVIgalK rev 5’ 
TCAGAAGCATCGTCGGCGCTTCAGGGATTGCACCCCCAGAT CAGCACTGTCC 
TGCTCCTT 3’ .The galK specific sequence is in italics and the pVI sequence is 
underlined. The final recombination products were sequenced and the virus was 
generated as described above. Briefly, Pac I linearized WT Ad5GFP and K45EK52E 
Ad5GFP viral genomes were transfected into 293β5 cells, followed by amplification in 
one additional passage. Infected cells from the second passage were collected at 48hrs 
post infection. The virus concentration from the cell lysates or supernatants was 
determined using qPCR analysis.  
VIRUS INFECTIVITY 
Virus infectivity was determined as previously described by measuring the 
expression of the GFP transgene (Wu, Fernandez et al. 2001) Briefly 100,000 HeLa cells 
were incubated for 24 hours with increasing concentrations of virus (gc/cell) in growth 
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medium. Cells were detached
 
and analyzed by fluorescence-assisted cell sorting in an 
Accuri
 
cytometer (Becton Dickenson, Franklin Lakes, N.J.). A threshold
 
established by 
the fluorescence of uninfected cells was used
 
to distinguish infected cells expressing 
GFP. 
QUANTITATIVE PCR ANALYSIS 
Viral DNA was isolated from supernatants using QIAamp DNA Mini kit (Qiagen) 
as directed by the manufacturer's instructions. The viral DNA was serially diluted and 
qPCR reactions that target the Ad hexon gene were performed using GoTaq qPCR master 
mix (Promega). Each reaction contained 10 μl of viral DNA and 40 μl of Master Mix The 
Master Mix was made up of 1x GoTaq qPCR Master Mix, and  100nM of the RTHexon 
for primer 5’ CAGGACGCCTCGGAGTACCTGAG 3’ and RTHexon rev primer: 
5’GGAGCCACCGTGGGGTT 3’. Thermal cycle conditions consisted of initial 
denaturation incubation at 95°C for 10 minutes followed by 44 cycles of alternating 95°C 
incubations for 15 seconds, 50°C incubations for 2 minutes and 60°C incubations for 1 
minute. Fluorescence was detected after every 60°C extension. For standard curves, 
qPCR was performed on a 10-fold dilution series of purified plasmid, hexon-pET15b, 
ranging from 1 × 10
1 
to 1 × 10
7 
copies/reaction. 
SITE DIRECTED MUTAGENESIS 
Generating pVI single tryptophan mutants 
To generate pVI containing single tryptophan residues, mutations were introduced 
in pET15bVI-N, a construct encoding residues 34–114. This region of pVI has only 3 
tryptophans, therefore to obtain single tryptophan mutants, 2 out of the 3 tryptophan 
residues were mutated to phenylalanine using the QuickChange II site-directed 
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mutagenesis kit (Strategene, La Jolla, CA). Three different mutants were generated using 
the following primers. Complementary primers are not shown. Altered nucleotides are 
indicated in bold. 
W37 (W41/59F): 
VIW59F 5′ GGCAGCAAGGCCTTTAACAGCAGCACAGG3′ 
VIW41F 5′ GCTGGGGCTCGCTGTTTAGCGGCATTAAAAATTTCG 3′ 
W41 (W37/59F):  
VIW59F 5′ GGCAGCAAGGCCTTTAACAGCAGCACAGG 3′ 
VIW37F 5′ ACAAGGCCTTCAGCTTTGGCTCGCTGTGGAGC 3′ 
W59 (W37/41F): 
VIW3741F 5′ GCTTTGGCTCGCTGTTTAGCGGCATTAAAAATTTCG 3′ 
To obtain single tryptophan mutants in the 2nd, 3rd and 4th predicted helices, the 
3 native tryptophans were first mutated to phenylalanine and various hydrophobic 
residues in these helices were then mutated to tryptophan using the QuickChange II site-
directed mutagenesis kit (Stratagene, La Jolla, CA). The no tryptophan construct was 
generated using the following primers. Complementary primers are not shown. Altered 
nucleotides are indicated in bold. 
VIW59F 5′ GGCAGCAAGGCCTTTAACAGCAGCACAGG 3′ 
VIW41F 5′ GCTGGGGCTCGCTGTTTAGCGGCATTAAAAATTTCG 3′ 
VIW37F 5′ ACAAGGCCTTCAGCTTTGGCTCGCTGTGGAGC 3′ 
The single tryptophan mutants were generated using the following primers: 
L67W 5′ ACAGGCCAGATGTGGAGGGATAAGTTGAAAG 3′ 
V80W 5′ AAAATTTCCAACAAAAGTGGGTAGATGGCCTG 3′ 
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L84W 5′ GGTGGTAGATGGCTGGGCCTCTGGCATTAGC 3′ 
V91W 5′ TCTGGCATTAGCGGGTGGGTGGACTGGCCAAC 3′ 
 Generating the L40Q, W37L40Q, W41L40Q, and W59L40Q mutants 
To generate L40Q single tryptophan mutants, the L40Q mutation was introduced 
in the single tryptophan mutant (W37, W41 and W59) constructs previously described 
using  the QuickChange II site-directed mutagenesis kit (Strategene, La Jolla, CA). Three 
different mutants were generated using the following primers. Complementary primers 
are not shown. Altered nucleotides are indicated in bold. 
VIW37FL40Q 5′ GCTTTGGCTCGCAGTGGAGCGGCATTAAAAATTTCG 3’  
VIW37FL40QW41F 5′ GCTTTGGCTCGCAGTTTAGCGGCATTAAAAATTTCG 3′  
VIW41FL40Q 5′ GCTGGGGCTCGCAGTTTAGCGGCATTAAAAATTTCG 3′  
The single point mutation L40Q was generated using the following primers: 
L40Q 5’ GCTGGGGCTCGCAGTGGAGCGGCATTAAAAATTTCG 3’ 
 Generating the K45E, K52E, K45EK52E, W37AK45E and W37AK52E mutants: 
The K45E and the K52E mutations were introduced into pET15bVIhis, containing the 
mature form of pVI, using the following primers. Complementary primers are not shown. 
Altered nucleotides are indicated in bold.  
K45E 5’ GTGGAGCGGCATTGAAAATTTCGGTTCCAC 3’ 
K52E 5’ CGGTTCCACCGTTGAAAACTATGGCAGCA 3’ 
To generate the W37AK45E and W37AK52E the primers listed above were used 
to insert the K45E and the K52E mutations in the pVIhis-W37A. The double lysine 
mutant was generated by inserting the K45E mutation into the K52E-pVI plasmid. 
 Generating the mutants with altered topology 
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The S1LT15L, S1QG8QS14Q and S1IG3IF12S were generated by introducing the 
mutations as described above in the pVI-his plasmid with the following primers. Altered 
nucleotides are indicated in bold.  
S1L   5’ AGCGGTGGCGCCTTCCTCTGGGGCTCGCTGTGG 3’ 
T15L 5’AAAAATTTCGGTTCCCTCGTTAAGAACTCTGGCAGC 3’ 
G8QS14Q 5’ GCTGTGGAGCCAGATTAAAAATTTCGGTCAGACCGTTAAGAA 3’ 
S1Q  5’ AGCGGTGGCGGCTTCCAGTGGGGCTCGCTGTGG 3’ 
F12S  5’CATTAAAAATTCCGGTTCCACCG 3’ 
S1IG3I 5’GCCTTCATCTGGGGCATCCTGTGG 3’          
The mutations were confirmed by sequencing, and the plasmids were used to 
overexpress proteins in E. coli. 
 
RECOMBINANT PROTEIN PURIFICATION 
Recombinant proteins were expressed in BL21(DE3) cells. Cultures inoculated 
with overnight culture were grown at 37 °C, until they reached an optical density at 600 
nm of 1.0. The NaCl concentration was then increased by adding an additional 0.9 g 
NaCl/L, and protein expression was induced by adding 1 mM IPTG (isopropyl-α-D-
thiogalactopyranoside) for 1 h. Cells were pelleted, resuspended in cell lysis buffer (1% 
Triton X-100, 25mM phosphate, 150 mM NaCl pH 7.5, 0.5 mg/ml lysozyme, 0.1 mg/ml 
DNAse and 1 mM PMSF (phenylmethylsulfonylfluoride)), and soluble protein was 
isolated by centrifugation at 13,000×g for 15 min at 4 °C. Recombinant proteins were 
purified with Talon cobalt resin using the manufacturer's protocol (BD Biosciences). 
Proteins were extensively dialyzed into 25mM Phosphate, 150 mM NaCl, and 10% (v/v) 
29 
 
 
 
glycerol pH 7.5 before flash freezing in liquid nitrogen. Aliquots were stored at −80 °C 
until use.  
 
LIPIDS 
1-Palmitoyl,2-oleoylphosphatidylcholine (POPC), 1-palmitoyl, 2-
oleoylphosphatidylserine (POPS), 1-palmitoyl,2-oleoylphosphatidylethanolamine 
(POPE), 1-palmitoyl-2-stearoyl(6′,7′-dibromo)-snglycero-3-phosphocholine 1-palmitoyl-
2-stearoyl (9′,10′-dibromo)-sn-glycero-3-phosphocholine and 1-palmitoyl-2-
stearoyl(11′,12′-dibromo)-sn-glycero-3-phosphocholine, 1,2-di-(9Z-octadecenoyl)-sn-
glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (nickel salt) 
(DOGS- NTA-Ni)  were purchased from Avanti Polar Lipids. α-Lysophosphatidylcholine 
(lysoPC) , N-fluoresceinyl-1, 2-ndihexadecylphosphatidylethanolamine (FITC-DHPE) 
and α-Lysophosphatidylcholine (lysoPC) were from Sigma, and N-fluoresceinyl-1, 2-
sndihexadecylphosphatidylethanolamine (FITC-DHPE) were obtained from Invitrogen 
 
pVI IN VITRO MEMBRANE LYTIC ACTIVITY 
Liposomes were prepare as previously described (Blumenthal, Seth et al. 1986) 
by mixing POPC and POPS (75:25 mol%), or POPC, POPS and DOGS-NTA-Ni 
(70:25:5 mol%)  in chloroform. A thin lipid film was then generated on a glass tube by 
evaporating the chloroform with a stream of nitrogen gas. Residual chloroform was 
removed by placing the tube under vacuum for 2 hours. The film was rehydraded with 
100 mM sulforhodamine B (SulfoB) (Molecular Probes) Liposomes containing entrapped 
SulfoB were separated from free dye using a Sephadex G-75 column, pre-equilibrated 
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with 25mMHEPES, 150mMNaCl bufferpH7.5 (HBS). The liposome concentration was 
determined using a phosphate assay as previously described (Fiske and Subbarrow, 
1925). Membrane lytic activity of recombinant pVI was determined by measuring SulfoB 
fluorescence dequenching upon release from liposomes. The liposomes were diluted in 
HBS to a final concentration of 10 μM. Different concentrations of pVI were then added 
to the liposomes and incubated for 20 min at 37 °C. Fluorescence intensity was measured 
using the Cary Eclipse fluorescence spectrophotometer (Varian) with the excitation 
wavelength of 575 nm and emission wavelength of 590 nm. One hundred percent dye 
release was determined by adding Triton X-100 to the liposomes at a final concentration 
of 0.5% (w/v). The percentage of SulfoB released was calculated using the formula % 
SulfoB released = 100 × [Fmeas − F0)/(Ftx100 − F0)], where Fmeas is the maximum 
fluorescence intensity measured, F0 is fluorescence intensity in absence of protein, and 
Ftx100 is the fluorescence intensity in the presence of 0.5% Triton X-100. 
 
PVI MEMBRANE BINDING  
Protein VI contains 4 tryptophans at residues 37, 41, 59 and 229. Binding to 
liposomes was assessed by monitoring changes in pVI intrinsic tryptophan fluorescence 
upon titration with increasing amounts of liposomes (POPC:POPS 75:25 mol% or 
POPC:POPS:DOGS-NTA-Ni 70:25:5 mol% ). This approach is routinely used for 
monitoring interactions between proteins and ligands, membranes or other proteins and 
relies on the assumption that the fractional spectral change in tryptophan fluorescence 
correlates directly with the amount of protein bound to its substrate (Eftink and Ramsay 
1997). PVI fluorescence emission spectra from 300–480 nm in HBS and at 37 °C was 
obtained by selective excitation of tryptophan at 295 nm. Increasing amounts of 
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liposomes were added to pVI with mixing for 3 min and additional spectra were obtained. 
Spectra of buffer or an equivalent amount of liposomes alone were subtracted from the 
spectra of each protein/lipid mixture to obtain corrected spectra. The spectral center of 
mass, Iλ, for the emission spectra were determined using the Carey Eclipse software. 
Assuming that this spectral change in tryptophan fluorescence correlates with the amount 
of protein bound, the fractional saturation of binding sites, θ, was calculated using the 
following equation: θ=(Iλ(obs)−Iλ(0))/(Iλ(max)−Iλ(0)), where Iλ(obs) is the spectral 
center of mass for each protein/lipid ratio and Iλ(0) and Iλ(max) is the spectral center of 
mass for protein alone and the protein in the presence of saturating amounts of liposomes, 
respectively. Plotting θ versus protein/lipid molar ratios yielded the resulting binding 
isotherms.  
 
ANALYSIS OF PVI MEMBRANE PENETRATION USING GIANT LIPID 
VESICLES (GLV) 
 
GLV were generated as described previously (Akashi, Miyata et al. 1996) by 
mixing POPC, POPS and FITC-DHPE (70:25:5 mol ratio) or POPC, POPS, DOGS-
NTA-Ni, FITC-DHPE (65:25:5:5 mol ratio) in chloroform. A thin lipid film was then 
generated on a glass tube by evaporating the chloroform with a stream of nitrogen gas. 
Residual chloroform was removed by placing the tube under vacuum for 6 h. The lipid 
film was then prehydrated with a stream of water saturated nitrogen gas for 25 min, 
followed by rehydration in 6 ml of HBS containing 0.1 M sucrose. The tube was then 
sealed with parafilm and incubated overnight at 37 °C. GLVs were harvested as a 
flocculate near the top of the solution the next day and quantified by phosphate assay as 
described above. Typical preparations of GLVs are polydisperse with vesicle diameters 
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ranging from 5 to 50 μm. To visualize pVI membrane lytic activity, recombinant pVI was 
incubated with GLV at a 1:100 (lipid:protein) ratio in HBS with 0.1 M glucose, on a glass 
slide. After 15 min the samples were analyzed by using an epifluorescence microscope. 
 
  TRYPTOPHAN DEPTH OF MEMBRANE PENETRATION 
Quenching of tryptophan fluorescence by brominated phospholipids was used to 
determine the depth of tryptophan penetration into the lipid bilayer (Chattopadhyay and 
London 1987; Ladokhin, Selsted et al. 1997). Liposomes containing 25 mol% POPS, 25 
mol% POPC and 50 mol% brominated phosphatidylcholine (Br2-PC) were made as 
described above. Recombinant pVI single tryptophan mutants were incubated for 10 min 
at 37 °C with brominated liposomes at a 1:100 (protein:lipid) ratio in HBS pH 7.5. The 
intensity of tryptophan fluorescence was measured at 325 nm upon excitation at 295 nm. 
The differences in quenching tryptophan fluorescence by the (6,7)-, (9,10)-, (11,12)-Br2-
PC was used to calculate the location of the residue in the bilayer using two methods: the 
parallax method  (Chattopadhyay and London 1987) and distribution analysis  (Ladokhin, 
Selsted et al. 1997). In the parallax method, the depth of the tryptophan residue was 
calculated using the formula:  
Zcf=Lcl+[(−ln(F1/F2)/πC–L
2
21]/2L21 
Lcl is the distance of the shallow quencher from the center of the bilayer, Lcl is the 
distance between the shallow and deep quencher, F1 is the fluorescence intensity in the 
presence of the shallow quencher, F2 is the fluorescence intensity in the presence of the 
deep quencher, and C is the concentration of quencher in molecules/Å
2
. In the 
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distribution analysis the depth of tryptophan residue was calculated by fitting the data to 
the equation: 
ln(F0/Fh)×c(h)=[S/σ(2π)
1/2]×exp[−(h−hm)
2
/2σ2] 
 where F0 represents the fluorescence intensity in the absence of the brominated 
phospholipids, Fh is the intensity measured as a function of the distance from the center 
of the lipid bilayer to the quencher h, c(h) is the concentration of the different quenchers, 
S is the area under the curve (measurement of quenching efficiency), σ is the dispersion 
(a measure of the distribution of the depth in the bilayer), hm is the most probable position 
of the fluorophore in the membrane, and h is the average bromine distances from the 
center of the bilayer, based on X-ray diffraction and taken to be 10.8, 8.3, and 6.3 Å for 
(6,7)-, (9,10)- and (11,12)-Br2-PC respectively. When equal concentrations of the Br-
lipids are used, the c(h) value is unity. 
 
IMMUNOFLUORESCENCE MICROSCOPY 
  A total of 1x10
5
 HeLa cells were plated on glass coverslips. The next day the cells 
were infected with 3x10
4
 vp/cell of Ad5gfp or ts1 or with 3000 pfu/cell of reovirus on ice 
for 1 hour after which the cells were shifted at 37°C to allow for virus internalization. At 
different times post virus internalization the cells were washed with PBS and fixed with 
4% paraformaldehyde (Electron Microscopy Sciences) in PBS for 15 min. The cells were 
then permeabilized with 0.5% (v/v) Triton X-100 (Sigma-Aldrich) for 2 min, washed 
with PBS and blocked for 1 hr in 10% FBS. Staining with specific mono- or polyclonal 
antibodies was done in 10% FBS for 1 hr. Galectin-3 was immunostained using a specific 
mouse monoclonal anti-Galectin-3 antibody (BD Transduction 556904) used at 1/100 
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dilution. Reovirus was immunostained using polyclonal reovirus antibody used at 1/200 
dilution, and pVI was detected with anti-pVI serum at 1/1000 dilution. For the 
K45EK52E galectin 3 experiment, virions were visualized using DyLight 488 labeled 
anti-hexon antibody at a 1/1000 dilution. Secondary Alexa Fluor 568-conjugated and 
DyLight 649-conjugated antibodies were used to visualize galectin-3 and pVI, 
respectively. Ad5gfp, and ts1 were prelabeled with Dylight 488 NHS-Ester Fluorophores, 
according to the manufacturer's protocol prior to use. Hoechst stain ( ImmunoChemistry 
Technologies) was used to counterstain nuclei before coverslips were mounted on glass 
slides with ProLong Gold (Invitrogen). Z-stack images were acquired with a DeltaVision 
microscope (Applied Precision) using a CoolSnap HQ digital camera (Photometrics) with 
a 1.4-numerical aperture (NA) 100× objective lens, and deconvolved with SoftWorx 
deconvolution software (Applied Precision). Images were assembled using IMARIS and 
ImageJ softwares. The percent galectin- 3 colocalizing with virus and/or pVI was 
determined using IMARIS software by first quantifying galectin 3 puncta as any 
punctuate signal in the TRITC channel above background. Any signal above background 
in the virus (GFP) or pVI (Cy5) channel was counted as galectin 3 association. A similar 
approach was used to determine the pVI percentage colocalizing with virus. 
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CHAPTER III 
EXPERIMENTAL RESULTS 
THE MECHANISM OF pVI IN VITRO MEMBRANE LYTIC ACTIVITY  
 The N-terminal amphipathic α-helix is important for pVI membrane lytic activity 
Currently there is no structural information regarding pVI. Secondary structure 
predictions suggest that the N-terminal 80 residues of mature pVI (residues 34–114) form 
a stable α-helical domain (Fig. 4A) (Wiethoff, Wodrich et al. 2005). The C-terminal 
domain is mostly disordered and contains a mixture of α-helical and β-structures. The 
membrane lytic activity of pVI was previously shown to be pH independent and strongly 
dependent on an N-terminus amphipathic α-helix (Wiethoff, Wodrich et al. 2005). To 
examine the importance of specific pVI domains for the observed membrane lytic 
activity, I and others in the lab had generated truncated versions of pVI.  I then measured 
the ability of these different proteins to disrupt membranes, by monitoring the release of 
an entrapped fluorophore (SulfoB) from the interior of liposomal membranes (Maier, 
Galan et al. 2010) (Fig 4B.). Wild type pVI caused a dose dependent release of SulfoB 
from liposomes. The truncated 80 residue N-terminal domain (VI114Δ) had similar 
membrane lytic activity as the full length pVI, suggesting that the C-terminal 125 
residues contribute significantly less to this process. Equivalent membrane lytic activity 
was also observed for a 24 residue peptide corresponding to the amphipathic α-helix 
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Fig . 4. Adenovirus protein VI disruption of and binding to liposomes.  
A) The predicted secondary structure of pVI with α-helices (cylinders) β-sheets (arrows) 
and unstructured (lines) secondary structures are displayed. Recombinant forms of pre-
pVI, pVI, VIΔ54, VI114Δ and VI34–54 were used in studies of membrane binding and 
permeabilization. B) PVI membrane lytic activity was measured by quantifying the 
release of SulfoB from liposomes after treatment with increasing concentrations of the 
different pVI constructs. C) Membrane binding of the different pVI constructs. Increasing 
lipid concentrations were added to pVI constructs and changes in tryptophan fluorescence 
were used to determine the fractional saturation (θ) of pVI binding capacity as described 
in the Materials and methods. Error bars represent the standard error of the mean for a 
minimum of 3 replicates. (■) Protein VI (◆) VI34–54 (▲) VIΔ54 (○) VI114Δ. (△) BSA 
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 (residues 34–54) with an additional C-terminal tetralysine tag to enhance aqueous 
solubility, suggesting that this helix was sufficient for in vitro membrane disruption. 
Removing the amphipathic α-helix (VIΔ54) greatly reduces membrane lytic activity, 
requiring ∼400-fold higher protein concentrations to elicit similar SulfoB release as the 
mature form of the protein. Since equivalent amounts of the irrelevant protein, bovine 
serum albumin, do not induce significant SulfoB release, our data with the truncated 
VIΔ54 protein suggest that additional residues within pVI may also facilitate membrane 
interactions.  
To further assess the role of the amphipathic α-helix in pVI membrane disruption, 
I examined the relative affinity of each protein construct and peptide for the same 
liposomal membranes (Maier, Galan et al. 2010).  The interaction between pVI and 
liposomes was determined using changes in intrinsic tryptophan fluorescence upon 
membrane association. By assuming that the relative change in tryptophan fluorescence 
upon binding liposomes was directly related to the amount of membrane bound pVI, I 
generated binding isotherms by plotting the fractional saturation of binding sites versus 
increasing lipid concentrations (Fig 4C.). While pVI, VI114Δ and VI34–54 all possessed 
similar affinities as evidenced by dissociation constants between 2– 4 μM, VIΔ54 
membrane affinity was ~600-fold lower. These results suggest that the N-terminal 
amphiphathic α-helix is important for membrane binding. Additionally, there is a strong 
correlation between the affinity of pVI for membranes and the in vitro membrane lytic 
activity. 
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PVI amphipathic α-helix membrane topology 
The pVI N-terminal amphipathic α-helix membrane topology is also of interest 
and could provide considerable insight into the mechanism of membrane disruption. 
Using the well documented distance-dependent quenching of tryptophan fluorescence by 
bromine atoms (Markello, Zlotnick et al. 1985), I determined the depth of the conserved 
W37, W41 and W59 residues in lipid membranes. These bilayers contained brominated 
lipid with bromine atoms covalently attached at specific positions on the lipid alkyl 
chains. Single tryptophan mutants of the 80 residue VI114Δ construct were made by 
mutating 2 out of the 3 tryptophans to phenylalanine since phenylalanine residues do not 
possess the fluorescent properties of tryptophan but have membrane binding properties 
most similar to tryptophan (Wimley and White 1996). Using this approach W37 and W41 
were found to be 9.6 and 10.6 Å from the center of the bilayer by parallax analysis (Fig. 
5A.)(Maier, Galan et al. 2010). The distance from the center of the bilayer Zcf, was 
determined both via parallax and distribution analyses (Chattopadhyay and London 1987; 
Ladokhin, Selsted et al. 1997). Interestingly, W59, which is outside the predicted N-
terminal amphipathic α-helix was also found to interact with the membrane, being 10.3 Å 
from the center of the bilayer. As a control for the assay, I found that the single 
tryptophan of melittin was 10.9 Å from the center of the bilayer, which is in good 
agreement with previously published reports which positions this tryptophan 10.8 Å from 
the bilayer center (Ghosh et al., 1997). Since W37 and W41 would be ~6 Å apart in an α-
helix, yet they are positioned at depths which differ by only ~1 Å in the membrane, it is 
likely that this helix is positioned in an oblique orientation relative to the membrane 
surface and does not traverse the apolar region of the lipid bilayer. The angle between  
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Fig 5. PVI amphipathic α-helix membrane topology. (A). The distances of W37, W41 
and W59 from the center of the lipid bilayer (Zcf) were calculated by distance-dependent 
quenching of tryptophan fluorescence. The Zcf values were calculated for each 
tryptophan residue using Parallax and Distribution analyses. (B) Residues 34–54 of Ad5 
protein VI were modeled as an α--helix using swisspdb viewer and overlaid on the three 
dimensional structure of POPC lipids in the Lcα phase (POPC128a.pdb, downloaded from 
http://people.ucalgary.ca/tieleman/download.html) such that the distance of W37 and 
W41 (green) were positioned at the distance from the center of the bilayer (Zcf) presented 
in A. 
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W37 and W41 would correspond to 10° from the bilayer–water interface. A model for the 
orientation of this helix on membranes is shown in Fig. 5B. 
PVI fragments membranes by inducing positive membrane curvature 
Since the above data suggest a superficial oblique orientation for the N-terminal 
α-helix, the key determinant of pVI membrane lytic activity, this protein may be inducing 
curvature stress in membranes leading to membrane disruption. To examine this 
possibility, I determined the effects of pVI on membrane morphology using giant 
fluorescent lipid vesicles (GLV). GLV membranes were labeled with 5 mol% 
fluoresceinylated lipid and observed by epifluorescence microscopy (Maier, Galan et al. 
2010). Vesicles appear 5–50 μm in diameter and this morphology is unchanged upon 
addition of PBS (Fig.6, top). Vesicles incubated with VIΔ54 (1:100 protein: lipid) 
appeared similar to PBS treated vesicles (Fig. 6, middle). Upon addition of pVI VI114Δ 
to GLVs at a protein:lipid molar ratio of 1:100, the vesicles were fragmented into smaller 
structures with an increased radius of curvature (Fig. 6, bottom). Of note, reorganization 
of lipid membranes into tubular structures (arrows) appears to result from pVI addition. 
This data supports the hypothesis that pVI fragments membranes by inducing significant 
membrane curvature stress.  
The observation that pVI fragments membranes by inducing membrane curvature 
is in line with one proposed mechanism of membrane disruption by cationic antimicrobial 
peptides (Brogden 2005). These peptides have been shown to fragment membranes either 
by inducing positive membrane curvature or negative membrane curvature (Campelo, 
McMahon et al. 2008) (Fig.7) To determine the type of membrane curvature  pVI 
induces, Debra Galan in our lab prepared liposomes entrapping SulfoB and containing 
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increasing amounts of lipids which have a preference to adopt either positively 
(lysophosphatidylcholine, lysoPC) or negatively (phosphatidylethanolamine PE) curved 
membranes. If pVI membrane lytic activity involves the induction of positive membrane 
curvature, then we would expect the presence of lysoPC to enhance pVI membrane lytic 
activity while PE would inhibit pVI membrane lytic activity. Since she observed exactly 
these effects of lysoPC and PE on pVI membrane lytic activity, we concluded that pVI 
disrupts membranes by inducing positive membrane curvature (Maier, Galan et al. 2010). 
In further support of this observation, the primary sequence of the N-terminal 
amphipathic α-helix of pVI fits recently identified criteria for helices which induce or 
associate with positively curved membranes (Drin, Casella et al. 2007). These helices 
typically possess a relatively small hydrophobic surface, few if any charged residues, and 
a hydrophilic surface which is composed mostly of short hydrophilic amino acids such as 
serine, threonine or glycine. 
Although results above demonstrate that pVI can fragment lipid membranes by 
inducing positive membrane curvature, they do not rule out the possibility that at lower 
pVI to lipid ratios, pore structures are formed. In fact, the toroidal pore model for peptide 
induced membrane permeabilization involves amphipathic α-helix induced positive 
curvature in membrane lipids such that the pore channel is lined both by peptide and lipid 
headgroups (Epand and Vogel 1999; Brogden 2005). To determine whether pVI induced 
size selective pores in lipid membranes, Debra compared the release of the 0.5 kDa 
SulfoB and 70 kDa FITC-dextran from liposomes incubated with increasing amounts of 
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Fig. 6. Protein VI fragments giant lipid vesicles.  
Fluorescein-DHPE labeled giant compared to those previously described for 
lipid vesicles were incubated with PBS (TOP), VIΔ54 (MIDDLE) or protein VI 
(BOTTOM) for 15 min before visualization by epifluorescence microscopy. Protein–lipid 
ratios were 1:100 (mol/mol). Arrows indicate tubular lipid structures formed in the 
presence of protein VI.  
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Fig. 7. Membrane curvature induction by amphipathic α-helices. 
Amphipathic α-helices that have a shallow membrane topology induce positive 
membrane curvature by bending the helix containing monolayer away from the from the 
protein. Negative curvature is induced by helices with a deeper membrane penetration, 
and this is mediated by bending the protein containing monolayer towards the protein 
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pVI at an overall lower ratio of protein to lipid. Previous studies have demonstrated that 
70 kDa FITC dextran has a hydrodynamic radius of 100 Å (Bohrer, Deen et al. 1979) and 
is unable to diffuse through membrane channels less than 50 Å in diameter (Ladokhin, 
Selsted et al. 1997). If a size selective pore were formed at these lower ratios of pVI to 
lipid, then we would expect that a greater release of sulfoB compared to FITC-dextran 
would be observed. Since Debra observed comparable degrees of fluorophore release 
from vesicles by pVI, we concluded that pVI does not form pores capable of 
discriminating between 6 and 100 Å diameter molecules (Maier, Galan et al. 2010). 
To summarize my in vitro data characterizing the mechanism used by pVI to lyse 
membranes, I propose the following model described in Fig 8. An N-terminal 
amphipathic α-helix in pVI is necessary and sufficient for membrane lytic activity. This 
helix binds membranes with an oblique orientation and a shallow membrane insertion, 
inducing positive membrane curvature stress. This curvature stress results in membrane 
fragmentation.  
  
PVI DOMAINS IMPORTANT FOR POSITIVE MEMBRANE CURVATURE 
INDUCTION 
 
Data described above suggests that pVI induces positive membrane curvature, 
however the pVI-lipid interactions necessary for generating this type of curvature are not 
known. I was first interested in understanding what pVI domains are involved in this 
process. Three possibilities exist:  the amphipathic α-helix alone induces the observed 
curvature, the helix cooperates with additional residues in this process, or the helix 
merely anchors pVI to membranes while the rest of the protein bends membranes.   
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 Fig. 8. Proposed model for pVI endosomal membrane lysis. 
PVI is release from the capsid interior during virus uncoating in the endosome. An 
amphipathic α-helix in pVI (yellow) anchors the protein to membranes by binding the 
lipid bilayer with an oblique shallow orientation. This binding fragments the endosomal 
membrane by inducing positive membrane curvature stress.  
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VIΔ54 has increased membrane lytic activity with DOGS–NTA–Ni liposomes 
Although the N-terminal amphipathic α-helix in pVI is largely responsible for 
membrane lytic activity, removing this helix does not completely abrogate the protein’s 
lytic activity. A construct that lacks this helix, VIΔ54, can still disrupt membranes but 
with much lower efficiency(Maier, Galan et al. 2010). This decreased lytic activity can be 
either due to inefficient membrane binding, or due to an inability to induce positive 
membrane curvature. Therefore, if residues in VIΔ54 participate in curvature induction, 
then enhancing this construct’s membrane affinity should increase lytic activity. We 
artificially enhanced VIΔ54 membrane affinity by appending an N-terminal 6×His-tagged 
tag to the recombinant protein and using liposomes containing 5 mol% of the Nickel-
chelating phospholipid, DOGS–NTA–Ni. The binding of His-tagged pVI constructs to 
liposomes was assessed as previously described using changes in intrinsic tryptophan 
fluorescence upon association to membranes (Maier, Galan et al. 2010). Compared to 
untagged VIΔ54, binding of 6×His-tagged VIΔ54 to DOGS–NTA–Ni containing 
liposomes displayed an apparent affinity much closer to that observed for pVI (Fig. 9A). 
Addition of a 6×His tag to pVI did not significantly enhance membrane affinity. To 
determine if this increased membrane binding correlates with increased membrane lytic 
activity, VIΔ54 was added to SulfoB-loaded DOGS–NTA–Ni liposomes and dye release 
was then measured. Addition of VIΔ54 to SulfoB-loaded DOGS–NTA–Ni liposomes 
resulted in increased membrane lytic activity compared to liposomes without the nickel-
chelating lipid (Fig. 9B). To control for the influence of the N-terminal 6×His tag on 
observed membrane lytic activity, similar titrations with purified 6×His-tagged penton 
base were performed. Tagged penton base did not induce significant SulfoB release over  
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Fig. 9. The membrane affinity and lytic activity of VIΔ54 are enhanced by DOGS–
NTA–Ni phospholipids. (A) Membrane binding of the different pVI constructs. 
Increasing lipid concentrations were added to pVI constructs and changes in tryptophan 
fluorescence were used to determine the fractional saturation (θ) of pVI binding capacity 
(B) Protein VI membrane lytic activity was determined by measuring the release of 
SulfoB from liposomes after incubation with increasing protein concentrations. 6×His-
pVI incubated with PC:PS:DOGS–NTA–Ni (70:25:5 mol%) (■) or PC:PS(70:25 mol% ) 
(□).6×His-VIΔ54 incubated with PC:PS:DOGS–NTA–Ni (70:25:5 mol%) (Δ) or PC:PS 
(75:25 mol%) (▲). 6×His- penton base incubated with PC:PS:DOGS–NTA–Ni (70:25:5 
mol%) (●).  
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 the same concentration range, suggesting that the His-tag was not responsible for the 
enhanced membrane lytic activity of VIΔ54 on DOGS–NTA–Ni liposomes. These results 
suggest that while the N-terminal amphipathic α-helix greatly enhances pVI membrane 
affinity, the remainder of the protein can also contribute to efficient membrane lysis 
(Maier and Wiethoff) . It is therefore possible that residues in VIΔ54 contribute to the 
induction of positive membrane curvature by pVI. 
Mapping membrane interacting domains within pVI 
An N-terminal 80 amino acid domain in pVI (residues 34–114) possesses 87% α-
helical content as assessed by circular dichroism (Maier, Galan et al. 2010). This domain 
is predicted to contain 4 α-helices (Fig 4A.), and I have previously shown that the first 
amphipathic α-helix has an oblique membrane orientation. Since residues outside this N-
terminal α-helix contribute to pVI lytic activity, I determined if additional predicted α-
helices in this 80 residue domain associate with membranes. Helical wheel diagrams 
suggest that each of these putative α-helices have considerable amphipathy (Fig 10A). In 
addition, predictions of the free energy of interfacial membrane partitioning, ΔGif, 
suggest that each of these helices would spontaneously associate with membranes 
although the magnitude of ΔGif for these 3 additional α helices is considerably smaller 
than that for the N-terminal α-helix (Fig 10A).  
To determine whether these α-helices interact with membranes, single tryptophan 
(Trp) mutations were introduced individually at 1 or 2 sites for each helix. These Trp 
residues replaced residues L67, L71, V80, L84 or V91 in the plasmid encoding a no Trp 
VI114Δ (the 3 native Trp residues were replaced by phenylalanine). The depth of Trp 
penetration into lipid bilayers was determined as described earlier by measuring 
49 
 
 
 
 
Fig 10. α-Helices in the N-terminal 80 residue domain of pVI interact with the 
membrane. Helical wheel diagrams of the different helices in the N-terminal 80 residue 
domain of pVI are shown, with the hydrophilic residues in white and hydrophobic 
residues in black. The residues in each helix mutated to tryptophan have been boxed. The 
free energy of partitioning into the lipid membrane interface, ΔGif, calculated using the 
Membrane Protein Explorer software  are shown for each helix with units of kilojoules 
per mole. (B) Depth of protein VI tryptophan residues penetration into the membrane  
 quenching of Trp fluorescence by brominated lipids.  
50 
 
 
 
To measure the depth of Trp membrane penetration, the single Trp mutants were 
incubated with PS:PC:PC–Br liposomes (25:25:50 mol%) at a 1:100 ratio (protein–lipid), 
and Trp fluorescence was then measured. Tryptophan fluorescence of each of these 
mutants was quenched upon mixing with brominated liposomes suggesting that these 
mutants interact with the lipid bilayer (Maier and Wiethoff). The distance from the center 
of the bilayer was calculated using both the parallax method and the distribution analysis 
(Fig 10B). Since the W67 and W71 residues in the 2nd helix, and W80 and W84 in the 
3rd helix would be ~6 Å apart in an α-helix, yet they are positioned at depths which differ 
by only ~1 Å in the membrane, it is likely that the 2nd and 3rd helices are positioned in 
an oblique orientation relative to the membrane surface. These helices do not traverse the 
apolar region of the lipid bilayer similar to the orientation reported for the N-terminal 
amphipathic α-helix. 
Induction of positive membrane curvature by the N-terminal amphipathic α-helix 
and VIΔ54  
The shallow and oblique membrane orientation observed with the α-helices within 
the N-terminal 80 residue domain is indicative of a protein that induces positive 
membrane curvature stress (Drin et al., 2007; Epand and Epand, 2000; Zimmerberg and 
Kozlov, 2006). Therefore, I hypothesized that these helices are contributing to the 
membrane curvature induced with full length pVI. To determine this contribution, I 
examined the influence lipids with a propensity to adopt positive (lysoPC) or negative 
(POPE) membrane curvature have on the membrane lytic activity of the N-terminal 
amphipathic α-helix or VIΔ54. If the membrane lytic activity of either the N-terminal 
amphipathic α-helix or VIΔ54 involves the induction of positive membrane curvature, 
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then I would expect the presence of lysoPC to enhance membrane lytic activity while 
POPE would inhibit membrane lytic activity. Similar to previous observations with pVI, 
the N-terminal amphipathic α-helix membrane lytic activity is significantly enhanced in 
the presence of increasing amounts of lysoPC while this activity is reduced in the 
presence of POPE (Fig. 11A). The membrane lytic activity of VIΔ54 is much less 
influenced by the inclusion of increasing amounts of lysoPC in liposomes and only 
slightly influenced by the inclusion of POPE (Fig. 11B). These data suggest that the 
residues 54–114 contribute more significantly to protein VI induction of positive 
membrane curvature than the rest of the protein.  
The N-terminal amphipathic α-helix and VIΔ54 cooperate to induce membrane 
tubule formation 
Since the amphipathic α- helix and residues in VIΔ54 can induce membrane 
curvature, I wanted to determine the latter’s contribution to pVI membrane lysis. As 
mentioned earlier, pVI membrane lytic activity involves the fragmentation of target 
membranes (Wiethoff, Wodrich et al. 2005; Maier, Galan et al. 2010). When added to 
fluorescently labeled giant lipid vesicles (GLV), this fragmentation also leads to the 
formation of tubular structures which likely possess significant membrane curvature 
stress. It was also shown that the ability of protein VI to induce tubule formation requires 
only the N-terminal 80 residues of pVI (Maier, Galan et al. 2010). To determine what 
domains in pVI are responsible for tubule formation I investigated the effects of N-
terminal amphipathic α-helix and VIΔ54 on GLV morphology. The GLV membranes 
with or without 5 mol% DOGS–NTA–Ni were labeled with 5 mol% fluoresceinylated 
lipid and observed by epifluorescence microscopy. Vesicles appear 5–50 μm in 
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Fig. 11. The amphipathic α-helix peptide and VIΔ54 induce positive membrane 
curvature. Increasing concentrations of VI34–54 (A) or VIΔ54 (B) were incubated with 
POPC:POPS (75:25 mol%) (A) or POPC:POPS:DOGS–NTA–Ni (70:25:5 mol%) (B). * 
indicates liposomes entrapping SulfoB and in which some POPC was replaced with 5 (■) 
or 10 (□) mol% lysoPC or 5 (▲) or 25 (Δ) mol% of POPE .The % SulfoB released was 
determined as described in the Material and Methods section  
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 diameter and this morphology is unchanged upon addition of PBS (Fig.10A ). The 
addition of full length pVI to GLVs at a protein:lipid molar ratio of 1:100 fragments 
vesicles into smaller structures, (Fig. 10B) including tubules (arrows). However, although 
the N-terminal amphipathic α-helix is able to disrupt these GLVs, it fails to form the 
highly curved tubular structures observed with full length protein (Fig. 10C). Incubating 
VIΔ54 with GLVs containing DOGS–NTA–Ni also results in membrane fragmentation 
without tubulation (Fig. 10D). These data suggest that although the N-terminal 
amphipathic α-helix is sufficient to induce positive membrane curvature and lyse 
membranes, the highly curved membrane tubules observed upon pVI membrane lysis 
require additional elements within residues 54–114 of pVI to interact with membranes. 
However, at this time the significance of pVI membrane tubulation during Ad entry is not 
understood.  
 
PVI AMPHIPATHIC α-HELIX MEMBRANE TOPOLOGY IS IMPORTANT 
FOR POSITIVE MEMBRANE CURVATURE INDUCTION 
 
Once I determined how the different domains in pVI contribute to positive 
membrane curvature induction and tubule formation, I was interested in understanding 
what additional protein-lipid interactions are important for this process. Studies with 
amphipathic α- helical peptides have shown that membrane topology dictates the type of 
curvature these peptides generate.  Peptides that penetrate deeper into the membrane 
induce negative membrane curvature, while those that have a shallow membrane 
insertion induce positive curvature (Fig. 7) Protein VI amphipathic α- helix has a shallow 
bilayer insertion is necessary for producing positively curved membranes. 
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Fig. 12. P VI domains involved in membrane tubule formation.  
Fluorescein-DHPE labeled POPC:POPS (75:25 mol%) (A–C) or POPC:POPS:DOGS–
NTA–Ni (70:25:5 mol%) (D). Giant lipid vesicles were incubated with PBS (A), pVI (B), 
VI34–54 (C) or VIΔ54 (D) for 15 min. Tubule formation was visualized by epifluorescence 
microscopy. Arrows indicate tubular lipid structures formed in the presence of pVI 
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To determine if amphipathic α-helix membrane topology dictates the type of membrane 
curvature pVI generates, we altered the depth of membrane penetration by two different 
approaches. In the first approach we increased the helix hydrophobic sector by mutating 
hydrophilic residues at the polar/nonpolar interface to hydrophobic residues (S1L/T15L 
mutant) (Kiyota, Lee et al. 1996). The other approach we used was to widen the 
amphipathic α- helix polar sector by mutating polar residues that have smaller side chains 
to polar residues with longer side chains (S1Q/G8Q/S14Q mutant). This allows the helix 
to penetrate deeper into the membrane due to the “snorkelling” effect of the longer side 
chains of Glutamine (Gln) residues. The bulk of the van der Waals surface area of these 
residues is hydrophobic, and can insert into the membrane while the polar moiety can 
extend into the aqueous environment. The presence of the longer hydrocarbon side chain 
of Gln at the polar/nonpolar interface, allows the peptide to penetrate deeper into the 
membrane (Mishra and Palgunachari 1996; Zelezetsky, Pag et al. 2005)  
To determine if these mutations in the amphipathic α- helix decrease pVI positive 
curvature induction, I measured membrane lytic activity in the presence of lysoPC (lipids 
that favour positive membrane curvature) or PE (lipids that favour negative membrane 
curvature) as described earlier. If amphipathic α- helix membrane topology dictates the 
type of curvature pVI induces, then a pVI mutant that penetrates deeper in the lipid 
bilayer should have decreased membrane lytic activity in the presence of lysoPC lipids, 
and increased activity in the presence of PE lipids. The results indicate that while the 
S1Q/G8Q/S14Q mutant is not impaired in positive curvature induction, the S1L/T15L 
mutant has diminished capacity to induce positively curved membranes (Fig 13). 
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Fig 13. Membrane curvature induction by pVI mutants with increased hydrophobic 
sector. (A) Liposomes containing different concentrations of lyso-PC  or PE, and 
entrapping SulfoB are made. Increasing concentrations of () WT ()S1Q/G8Q/S14Q 
()S1L/T15L are incubated with 10uM of these liposomes, and SulfoB release is then 
measured. A positive on this graph is indicative of a protein that induces positive 
curvature, while a negative slope correlates with a protein that induces negative 
curvature. (B) Helical wheel diagrams S1Q/G8Q/S14Q and S1L/T15L mutants depicting 
the altered nucleotides. Hydrophobic sector is the area under the lines.  
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Studies with fusion peptides have shown that a tilted helix membrane topology is 
necessary to induce negative curvature and subsequent fusion (Epand, Epand et al. 2001). 
The tilt angle of the fusion peptide in its inactive state (at neutral pH) is 23°, and in its 
active form (acidic pH) is 38° (Han, Bushweller et al. 2001). The deeper membrane 
penetration observed at lower pH is necessary for negative curvature induction (Lai and 
Tamm ; Epand, Epand et al. 2001; Lai, Park et al. 2006). My in vitro studies suggest that 
pVI has an oblique membrane topology, with a tilt angle of 10°, however it is not known 
if this orientation is necessary for producing positive membrane curvature. To change the 
amphipathic α- helix membrane orientation, I introduced mutations that resulted in a 
more hydrophobic N terminus and a less hydrophobic C terminus (S1I/G3I/F12S). This 
would allow the N terminus to penetrate deeper in the membrane while the C terminus of 
the amphipathic α- helix would have a shallow membrane insertion, thereby tilting the 
helix.  
Once I generated this mutant protein I determined its ability to induce positive 
membrane curvature as described earlier. If pVI amphiphatic α-helix membrane topology 
dictates the induction of positive membrane curvature, then a mutant that has a tilted 
membrane orientation should have a defect in inducing this type of curvature. As a 
control I used the influenza fusion peptide which is known to induce negative membrane 
curvature. The results indicate that the tilted helix mutant has a defect in inducing 
positive curvature (Fig 14.). The same results were also observed with a peptide that 
contains the S1I/G3I/F12S mutant helix. Taken together these data suggest that the 
orientation of the amphipathic α-helix on membranes is important for positive membrane 
curvature induction. 
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Fig. 14. Membrane curvature induction by tilted helix mutant pVI. (A) Liposomes 
containing different concentrations of lyso-PC or PE, and entrapping SulfoB are made. 
Increasing concentrations of () WT  (×) Influenza FP () S1I/G3I/F12S protein and 
() S1IG3IF12S peptide are incubated with 10uM of these liposomes, and SulfoB 
release is then measured. The slope for each line is shown in the same colour as the line. 
A positive on this graph is indicative of a protein that induces positive curvature, while a 
negative slope correlates with a protein that induces negative curvature (B) S1IG3IF12S  
helical wheel diagram indicating the altered residues 
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POSITIVELY CHARGED AND HYDROPHOBIC RESIDUES IN THE 
AMPHIPATHIC α-HELIX ARE IMPORTANT FOR THE IN VITRO 
MEMBRANE LYTIC ACTIVITY OF PVI 
 
My in vitro data suggests that pVI amphipathic α-helix is the key determinant of 
pVI membrane binding and subsequent lysis. However the role of this helix in Ad 
endosomal escape is not known. I was therefore interested in understanding what helix-
membrane interactions are important for Ad endosomal escape. To address this question, 
I had to first determine what residues in the amphipathic α-helix are important for in vitro 
membrane binding. Protein attachment to membranes can be mediated by electrostatic 
interactions between positive residues on the protein and the negatively charged lipid 
head groups, as well as interaction between hydrophobic residues and the hydrocarbon 
core of the bilayer. Preliminary data in our lab indicates that mutations in the amphipathic 
α-helix that affect the hydrocarbon sector thickness (W37AW41A) decrease pVI 
membrane lytic activity. I predict that this decreased membrane lytic activity is due to 
decreased membrane affinity, suggesting that hydrophobic residues are important for 
helix membrane binding. Furthermore, Debra Galan in our lab has shown that 
electrostatic interaction between pVI and membranes is important for pVI lytic activity. 
This electrostatic interaction is potentially mediated by the interaction of two positively 
charged lysine (Lys) residues in the amphipathic α-helix with the negatively charged lipid 
head groups.  Based on these preliminary studies I hypothesized that hydrophobic and 
charged residues in the amphipathic α- helix are necessary for pVI membrane binding.  
To test this hypothesis I generated a series of mutants that have positively charged Lys 
residues replaced with negatively charged glutamate (Glu)  (K45E, K52, K45EK52E), or 
mutants that affect both the charge and helix hydrophobicity (W37AK52E and 
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W37AK45E).  I then determined the membrane lytic activity of these pVI mutants by 
monitoring the release of SulfoB from liposomes as described earlier.  If hydrophobic and 
positively charged amino acids in the helix are important for pVI membrane binding, then 
mutations that alter the charge and hydrophobicity should decrease pVI membrane 
affinity, and subsequent membrane lytic activity. As predicted, I observed a decrease in 
membrane lytic activity with these mutants (Fig 15A). This decrease in lytic activity 
correlates with a decrease in membrane affinity (Fig 15B) 
We identified additional helix-membrane interactions necessary for pVI 
membrane lytic activity, when our collaborators recovered a mutant Ad with a 10 fold 
decrease in endosomal escape (Moyer, Wiethoff et al.). This virus has a mutation (L40Q) 
in pVI amphipathic α- helix which changes the hydrophobic residue leucine (Leu) to the 
hydrophilic residue glutamine (Gln). Since this mutation would decrease pVI overall 
hydrophobicity, I hypothesized that the defect in endosomal escape is due to decreased 
pVI membrane affinity.  Using purified recombinant protein and liposomal membranes, I 
found that the L40Q mutant has a 10 fold decrease in membrane lytic activity compared 
to WT pVI (Fig 15A). This decrease in membrane lytic activity correlates with a 10 fold 
decrease in membrane affinity (Fig 15B)(Moyer, Wiethoff et al.). These data confirm my 
findings that hydrophobic residues in the amphipathic α-helix are important for pVI 
membrane lytic activity.  Furthermore, these results also show that hydrophobic  
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Fig. 15. Hydrophobic and positively charged residues are important for pVI activity. 
(A) Increasing concentrations of the different pVI constructs was added to liposomes and 
SulfoB release was measured. (B) Membrane binding of the different pVI constructs. 
Increasing lipid concentrations were added to pVI constructs and changes in tryptophan 
fluorescence were used to determine the fractional saturation (θ) of pVI binding capacity. 
Error bars represent the standard error of the mean for a minimum of 3 replicates. 
(■) WT (◆) K45E () K52E (▲) W37AK45E (Δ) W37AK52E () K45EK52E () 
VIΔ54  
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interactions between this helix and the endosomal membrane are important for Ad 
endosomal escape. 
The amphipathic α-helix has an oblique membrane orientation, and this 
orientation is important for the type of curvature stress pVI induces. I wanted to 
determine if replacing the hydrophobic Leu residue with the hydrophilic Gln alters pVI 
membrane topology. The L40Q mutation was introduced in the single Trp constructs 
W37, W41 and W59, and the depth of membrane penetration was determined as 
previously described, by measuring Trp fluorescence quenching by brominated lipids. 
Interestingly, I found that these lipids do not quench the fluorescence for residues W37 
and W41, while the depth of W59 membrane penetration is similar to WT (Fig 17) These 
data suggest that residues in the N terminus of the helix fail to interact with the 
membrane (Moyer, Wiethoff et al.). This was seen at protein concentration where L40Q 
is maximally bound to membranes, suggesting that amphipathic α-helix membrane 
topology might also contribute to pVI membrane lytic activity and Ad endosomal escape. 
 
GALECTIN- 3 AS A MARKER FOR ADENOVIRUS-PERMEABILIZED 
ENDOSOMES 
 
Galectin-3 is forms punctate structures during Ad entry. 
Non-enveloped viruses have developed different mechanisms of permeabilizing 
their limiting membrane. Viruses such as reovirus induce the formation of size selective 
pores in membranes (Agosto, Ivanovic et al. 2006), while Ads use a different mechanism 
(Prchla, Plank et al. 1995). My in vitro data suggests that the membrane lytic activity of   
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Fig. 16.The L40Q mutation attenuates membrane lysis and affinity. (A) SulfoB-
entrapped liposomes were incubated with increasing concentrations of purified  ()WT, 
() L40Q, or  ()VIΔ54 and the released dye was measured. (B) Membrane binding of 
various VI constructs was determined by monitoring changes in intrinsic tryptophan 
fluorescence following incubation with increasing amounts of lipid. The data shown are 
reported as the means ± SEM from three independent experiments. 
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 Fig 17. The L40Q mutation alters amphipathic α-helix membrane topology.  
(A) Insertion depths of three tryptophan residues (W37, W41, and W59) inserted into 
brominated phospholipids were measured independently via tryptophan fluorescence 
quenching. BSA was included as a negative control. (B) Depth of membrane penetration 
for the different tryptophan residues (Zcf)  
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pVI involves the fragmentation of target membranes. This gross membrane 
reorganization observed in my in vitro studies is consistent with previous observations 
that Ad can facilitate the cytosolic translocation of 70kd dextrans or whole virions 
(Brabec, Schober et al. 2005; Farr, Zhang et al. 2005). Although these data suggest that 
Ad disrupts the endosomal membrane, virus translocation from the internal to the 
external side of the disrupted endosomal membrane has not been documented. 
Recently, a marker for vacuole lysis during bacterial infection has been identified. 
This marker is the cytosolic protein galectin- 3 (Gal-3) (Paz, Sachse et al.). Gal-3 labels 
disrupted vacuolar membranes by binding cell surface N-linked glycans when these are 
exposed following vacuole lysis. Binding of Gal-3 to membrane fragments can be 
visualized by immunofluorescence microscopy as punctate structures. To determine if 
Gal-3 labels disrupted endosomal membranes during Ad entry, I infected HeLa cells with 
fluorescently labeled virus, and 30 minutes post infection the cells were fixed and stained 
for Gal-3. A separate set of HeLa cells were infected with reovirus, which has been 
shown to form size selective membrane pores, or ts1, a temperature-sensitive mutant Ad 
which fails to disrupt the endosome.  Gal- 3 accumulates in punctate structures in Ad 
infected cells (Fig 18B), and is diffusely distributed in the cytoplasm and nucleus of 
uninfected cells (Fig 18A). The diffuse staining was also observed in cells infected with 
ts1 or reovirus (Fig 18C and D). When I quantified the number of Gal-3 puncta per cell I 
saw a statistically significant difference in the number of puncta per cell in Ad infected 
cells compared to cells infected with ts1 and reovirus, or uninfected cells. These data 
suggest that Gal- 3 labels disrupted endosomal membranes during Ad entry.  
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Fig. 18. Galectin 3 accumulates in punctate structures in Ad5 infected cells. 
 HeLa cells were either uninfected (A) or infected with fluorescently labeled Ad5 (B) 
Ad2ts1 (C) or reovirus (D) and at 30min post infections the cells were fixed and stained 
for galectin-3 or virus (reovirus).  The number of galectin 3 puncta per cell was then 
counted. Bar represents 5m  
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Fig. 19.The number of galectin 3 puncta increases with increasing virus 
concentration. HeLa cells were infected with increasing concentrations of fluorescently 
labeled Ad5, and at 30min post infections the cells were fixed and stained for galectin-3.  
The number of galectin-3 and virus puncta per cell was then counted.   
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If Gal-3 accumulates on disrupted endosomal membranes during Ad infection, increasing 
the virus concentration should increase the number of disrupted endosomes, and therefore 
the number of Gal- 3 puncta. A similar experiment as described earlier was performed, by 
infecting cells with increasing virus concentrations and monitoring the accumulation of 
Gal-3 puncta. The number of Gal-3 punctate structures increased with increasing virus 
concentrations, confirming our initial findings that this marker labels disrupted 
endosomes during Ad infection (Fig. 19). 
Time course for Gal-3 accumulation on membranes 
Cryo-electron microscopy studies suggest that pVI is buried within the capsid 
interior inside the hexon cavity (Saban, Silvestry et al. 2006). During virus uncoating in 
the acidified endosome, pVI is released from the capsid(Greber, Willetts et al. 1993). The 
release of pVI was previously shown to be a requirement for in vitro membrane lytic 
activity of the Ad virion (Wiethoff, Wodrich et al. 2005) Therefore I hypothesize that the 
Gal-3 structures form only after protein VI is released from the capsid.  
To determine the timing of Gal-3 accumulation on disrupted endosomal 
membranes I synchronously infected HeLa cells by bind fluorescently labeled virus at 4° 
C and, after washing away unbound virus, allowed for virus internalization by warming 
cells to 37° C. At different times post virus internalization the cells were fixed, and using 
immunofluorescence microscopy I visualized the release of pVI from internalized virions 
as well as the formation of Gal-3 puncta. Protein VI release from capsids begins at 10 
min post virus internalization which is consistent with published observations of 
adenovirus uncoating during cell entry (Fig 20A) (Wodrich, Henaff et al. 2010). 
Consistent with our previous data the Gal-3 positive structures only form at 20 min post 
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virus internalization after pVI has already been released from the endosome (Fig  20A). 
These data confirm our findings that Gal-3 labels disrupted endosomal membranes, since 
the membrane lytic factor has to be released from the capsid interior in order for the Gal-
3 structures to form. 
  After endosomal escape the partially disassembled virion travels on microtubules 
toward the nucleus where it docks at the nuclear pore to deliver its genome into the 
nucleus (Strunze, Trotman et al. 2005; Smith, Cassany et al. 2008). If Gal-3 labels Ad 
lysed endosomal membranes, then early during infection Gal-3 structures should contain 
virus that is escaping from the endosome. However after 1 hr when the virus docks at the 
nuclear pore, these structures should no longer colocalize with virus. Furthermore, the 
disrupted Gal-3 positive membranes should also contain pVI throughout the infection. I 
used image analysis software to determine the percentage of Gal-3 which colocalizes 
with virus or pVI at different times post virus internalization in the time course 
experiment described above. When the Gal-3 structures first form, 70% of these 
structures colocalize with virus and this colocalization decreases to 50% at later times in 
infection. (Fig. 20B). These data suggest that the virus is moving away from the Gal-3 
positive membranes. While the colocalization of Gal-3 with virus decreases, the 
percentage of Gal-3 colocalizing with pVI alone remains similar throughout the infection 
(Fig 20B).  Furthermore, when I determined the number of pVI and Gal-3 puncta per cell, 
I observed a similar trend with a peak at 30 minutes and decrease by 1 hr for both Gal-3 
and pVI (Fig 20C). Taken together these data suggest that pVI and Gal-3 decorate the 
same membrane fragments.  
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Fig. 20. Time course of galectin 3 accumulation during Ad entry.  Fluorescently 
labeled Ad5 was bound to HeLa cells for 1hr after which the cells were washed and 
shifted to 37C to allow for virus internalization. A) Cells were fixed and stained for pVI 
and galectin 3 at different time post virus internalization. Inserts represent an enlarged 
view of galectin 3 puncta. Virus is in green, pVI in blue and galectin 3 in red B) Using 
image analysis software we determined the percent galectin 3 colocalizing with Ad5, 
pVI, both or galectin 3 alone for each time point. C) The number of () galectin 3  and 
() pVI puncta per cell was counted for each time point.  
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Ad endosomal escape visualized in real time 
Labeling disrupted endosomes with Gal-3, gave us the opportunity to visualize Ad 
endosomal escape in real time. Until now, this process has been measured as the 
translocation of membrane impermeable toxins(Moyer, Wiethoff et al. ; Wiethoff, 
Wodrich et al. 2005) and antibody–toxin conjugates (FitzGerald, Padmanabhan et al. 
1983) across the endosomal membrane. Our collaborator, Harry Wodrich, infected Gal-3-
RFP expressing cells with a fluorescently labeled Ad, and 10 minutes post infection he 
visualized the cells by live cell imaging. He observed a number of virions escaping Gal-3 
positive endosomes, indicative of virions that are in the process of escaping the lysed 
endosome. Virions lysing the endosomal membrane were also captured, and visualized as 
Gal-3 puncta forming around virus. These data confirm our findings that Gal-3 can serve 
as a marker for Ad endosomal escape. Our studies are the first to directly show a 
nonenveloped virus translocating across disrupted membranes. 
 
ELECTROSTATIC INTERACTIONS BETWEEN PVI AND MEMBRANES 
ARE IMPORTANT FOR ADENOVIRUS ENDOSOMAL ESCAPE 
 
Currently, the mechanism used by Ad to disrupt the endosomal membrane during 
cell entry is not clear. Identifying a marker for disrupted endosomal membranes, can 
serve as a tool not only for visualizing Ad endosomal escape in real time, but also to 
determine what pVI-membrane interactions are important for this process. Viruses with 
mutations in pVI that decrease membrane lytic activity can be generated, and a defect in 
endosomal lysis can be evaluated by measuring Gal- 3 accumulation.  
  My in vitro studies suggest that positively charged residues in the amphipathic α- 
helix are important for pVI membrane binding. Together with our collaborators, we have 
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also shown that an interaction between this helix and the membrane is important for Ad 
endosomal escape (Moyer, Wiethoff et al.). Therefore, I hypothesized that an electrostatic 
interaction between pVI amphipathic α- helix and the endosomal membrane is necessary 
for Ad endosomal escape. If my hypothesis is correct, then recombinant viruses with Lys 
to Glu mutations in pVI amphipathic α- helix should have a defect in endosomal escape.  
Recombinant viruses with Lys to Glu mutations in pVI amphipathic α-helix have 
decreased infectivity 
To test this hypothesis, I generated the K45E and K45EK52E recombinant viruses 
and determined their infectivity. To generate these mutants, I introduced the mutations in 
Ad5GFP, a replication defective virus construct that lacks the E1, E3 genes and has a 
GFP expression cassette under the control of a CMV promoter. The mutant viral genomes 
were transfected into 293 cells, and passaged a number of times, after which the 
recovered virus was purified using a CsCl gradient as previously described (Wu, Trauger 
et al. 2004). Interestingly, during the first few passages I observed that the double Lys 
mutant (K45EK52E) was growing slower then WT, however this defect was not observed 
at later passages. When I sequenced pVI from the purified viral genome I found that the 
K45EK52E virus had reverted by the third passage to a single K45E mutation. This initial 
observation suggested that the two positive charged Lys residues are important for virus 
spread. To prevent the virus from reverting I collected the supernatants containing virus 
on passage two and quantified virus using quantitative PCR. 
To determine if the K45E virus has decreased infectivity, I infected HeLa cells 
with varying virus particles/cell of either WT or mutant pVI, and 24 hrs post infection I 
quantified the percent GFP positive cells. Since the virus cannot replicate in this cell line, 
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this experiment is measuring only virus entry. Therefore if the amphipathic α-helix 
membrane binding is necessary for Ad cell entry, I should see a decrease in specific 
infectivity with the K45E virus compared to WT. Our results however suggest that the 
K45E infectivity is similar to WT (Table 1), suggesting that a more significant decrease 
in membrane binding may be required to observe decreased Ad entry. Therefore I 
performed a similar experiment using the K45EK52E virus since membrane affinity is 
decreased about 40 fold when both Lys 45 and Lys 52 are mutated to Glu. The results 
indicate that at the same virus concentration there is a decrease in the percent GFP 
positive cells in cells infected with mutant virus compared to WT. Using the endpoint 
dilutions, I quantified infectivity and determined that the K45EK52E supernatants have a 
4 log decrease in infectious virus compared to WT, suggesting that the mutant virus has 
an entry defect (Table 2).  
The K45EK52E recombinant virus has a defect in endosomal escape 
To determine if the decreased infectivity is due to a defect in endosomal escape, I 
monitored the accumulation of the vacuole lysis marker, Gal-3, to disrupted endosomal 
membranes in cells infected with either K45EK52E or WT virus.  Gal-3 binding 
membrane fragments was visualized by immunofluorescence as punctate staining. My 
results show punctate Gal-3 staining in cells infected with WT virus, and diffuse staining 
in uninfected cells or cells infected with the K45EK52E virus, suggesting that this virus 
has a defect in disrupting the endosome (Fig 21).  From these data I concluded that an  
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Fig. 21. Ad5 K45EK52E virus has a defect in endosomal lysis. (A) HeLa cells were 
infected with Ad5 WT or Ad5 K45EK52E and at 30min post infections the cells were 
fixed and stained for galectin-3 or the viral protein hexon.  (B) The number of galectin- 3 
puncta per cell was then counted.  
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electrostatic interaction between the pVI amphipathic α- helix and the endosomal 
membrane is important for Ad endosomal escape. 
Since pVI can also function to stabilize the capsid, an observed defect in Ad 
endosomal escape could also be attributed to a defect in pVI release from the capsid 
interior during uncoating.  To rule out an uncoating defect with the K45EK52E virus, I 
infected cells with either WT or mutant virus and at 30min post virus internalization, I 
fixed and stained the cells for pVI and hexon. If the mutant virus has an uncoating defect 
pVI, staining should not be detected. However, a similar amount of pVI is released by 
both WT and K45EK52E (Fig 22). These data confirm that the K45EK52E pVI is 
released from the capsid but has a defect in endosomal lysis. Furthermore we observed 
that in cells infected with the mutant virus, 70% of pVI colocalized with the virus, while 
in cells infected with WT virus only 30% of pVI colocalized with virus (Fig 22B). These 
data further support our hypothesis that pVI is released from the capsid but is defective in 
endosomal escape. 
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Fig. 22. Ad5 K45EK52E virus does not have an uncoating defect. 
(A) HeLa cells were infected with Ad5 WT or Ad5 K45EK52E  and at 30min post 
infections the cells were fixed and stained for pVI or hexon. (B) The percentage of pVI 
colocalizing with virus was quantified using IMARIS image analysis software. 
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CHAPTER IV 
DISCUSSION 
ADENOVIRUS MEMBRANE DISRUPTION IS DISTINCT FROM OTHER 
NONENVELOPED VIRUSES 
 
The molecular mechanisms of cell membrane disruption by capsid proteins of 
nonenveloped viruses are still poorly defined. While studies have demonstrated that 
reovirus μ1 protein (Ivanovic, Agosto et al. 2008) and picornavirus VP1/VP4 (Tosteson 
and Chow 1997) form pores in membranes, much less is known regarding the 
mechanisms used by other nonenveloped viruses to penetrate cell membranes. While it 
has been clearly demonstrated that Ad, a non-enveloped virus, disrupts the endosomal 
membrane during cell entry, the mechanism has not been characterized (Meier and 
Greber 2003). Recent studies suggest that Ad pVI, which is released from the interior of 
the capsid during cell entry, has all of the in vitro membrane lytic activity of the virion 
(Wiethoff, Wodrich et al. 2005). These data suggest that pVI is involved in Ad escape 
from the endosome. Work presented in this dissertation supports a role for pVI in Ad 
endosomal escape, and proposes a mechanism for this process that is different from other 
nonenveloped viruses.  
A common theme in nonenveloped virus entry is membrane disruption by small 
hydrophobic proteins or peptides. The membrane lytic factor for Flock House virus, an 
insect virus, is a 4kD γ peptide. This peptide contains an N terminal amphipathic α- helix 
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called γ1, which is sufficient to disrupt membranes in vitro (Maia, Soares et al. 2006). 
Reovirus was also shown to use a hydrophobic peptide μ1 to disrupt membranes. An N 
terminal myristolated cleavage product, μ1N is sufficient to permeabilize the membranes 
of red blood cells. Similar to these nonenveloped viruses, the major determinant of pVI 
lytic appears to be a 20 residue putative N-terminal amphipathic helix (Wiethoff, 
Wodrich et al. 2005). Removing this helix greatly decreases pVI membrane binding and 
lytic activity (Wiethoff, Wodrich et al. 2005). I confirmed this finding, and further 
determined that a peptide containing this helix is sufficient for in vitro membrane lytic 
activity (Maier, Galan et al. 2010)    
However unlike the FHV and reovirus lytic peptides which are thought to form 
size selective membrane pores, Ad pVI disrupts membranes through a different 
mechanism. In addition to pore formation, lipid bilayers can be lysed by the induction of  
significant membrane curvature stress. The amphipathic helix of pVI possesses a 
conserved primary sequence found in many membrane associated proteins which 
correlates with their association with positively curved membrane surfaces (Drin, Casella 
et al. 2007). This helix binds to membrane surfaces in an oblique orientation, a 
characteristic of proteins that induce positive membrane curvature. In addition, my data 
and those of others in the lab demonstrate that pVI membrane lytic activity is enhanced 
by membranes with an increased propensity to form positively curved membranes and is 
decreased by membranes with a greater propensity to adopt negatively curved structures 
(Maier, Galan et al. 2010). Thus, these observations support a model in which pVI lyses 
membranes by inducing positive curvature in target membranes. Parvoviral capsids 
deploy a phospholipase A2 enzyme which hydrolyzes phospholipids to release the 
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positive curvature inducing-lysolipids, although a role for curvature stress has yet to be 
reported for parvoviral escape from endosomes (Zadori, Szelei et al. 2001; Farr, Zhang et 
al. 2005; Lupescu, Bock et al. 2006).  
Induction of membrane curvature stress by lytic proteins results in a detergent- 
like membrane fragmentation. Previously, it was proposed that Ad5 pVI disrupts 
membranes by fragmentation (Wiethoff, Wodrich et al. 2005). The oblique orientation of 
the N-terminal amphipathic helix, as well as pVI ability to induce  positive membrane 
curvature support these initial findings (Epand and Vogel 1999; Epand and Epand 2000).  
This more severe reorganization of membranes via pVI could facilitate the translocation 
of a 90 nm diameter capsid across endosomal membranes. Additionally, Ad has been 
shown to facilitate the cytosolic translocation of other viruses such as a 25 nm diameter 
Minute Virus of Mice further supporting a gross reorganization of endosomal membranes 
by Ad (Farr, Zhang et al. 2005). My results suggest that pVI disruption of membranes 
does not likely involve the formation of pores with diameters less than 100 Å and it is 
unlikely that a 22 kDa or perhaps a 20 residue peptide would be able to induce stable 
pores with larger diameters (Maier, Galan et al. 2010). 
Using epifluorescence microscopy to examine the ability of pVI to reorganize 
fluorescently labeled giant lipid vesicles, I and others in the lab confirmed previous 
observations that pVI fragments lipid membranes as seen by negative stain TEM 
(Wiethoff, Wodrich et al. 2005). However, negative stain TEM involves substantial 
dehydration of lipid membranes leading to potentially artifactual structures. Our current 
study employed fully hydrated membranes in which only the lipid membranes and not 
potential protein aggregates were visualized, therefore providing greater confidence in 
81 
 
 
 
the observation that pVI fragments membranes. Additionally, examination of pVI 
membrane lysis in solution has allowed us to visualize novel tubular structures possessing 
highly curved surfaces not previously observed by TEM (Maier, Galan et al. 2010). 
Although my data indicate that the pVI amphipathic α-helix is sufficient to lyse liposomal 
membranes, I determined that this helix is not sufficient to generate these highly curved 
tubular structures (Maier and Wiethoff). I was therefore interested in understanding what 
additional domains in pVI contribute to tubule formation. 
 My work has identified that the in vitro lytic activity of pVI is contained in an N 
terminal 80- residue helical domain (VI114Δ) (Maier, Galan et al. 2010). In addition to 
the N-terminal amphipathic α-helix, three additional α-helices are also predicted for this 
domain. These α-helices are also expected to spontaneously associate with membrane 
interfaces as evidenced by the negative ΔGif values. These predictions were confirmed by 
my observation that these 3 helices associate with membranes, binding in shallow oblique 
orientations in the lipid bilayer. The magnitude of these ΔGif  are considerably less than 
that for the N-terminal amphipathic α-helix which is in agreement with the severe 
reduction in membrane affinity observed for VIΔ54 (a construct that lacks this helix) 
compared to pVI. To examine the contributions of these additional α-helices to pVI 
membrane lytic activity, the affinity of VIΔ54 for membranes was artificially enhanced 
using Ni2+–NTA containing lipids in the target membrane and a 6×His tag on the 
protein. The increased affinity of 6×His–VIΔ54 for membranes correlated with an 
increase in membrane lytic activity which was more comparable to that observed for pVI 
(Maier and Wiethoff). Although the affinity of the various forms of pVI for membranes 
correlates with membrane lytic activity this relationship appears to be non-linear since the 
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6×His–VIΔ54 binding to Ni2±–NTA liposomes is less than pVI yet possesses similar 
membrane lytic activity.  
The ability of residues outside the N terminal amphipathic α-helix to interact with 
and disrupt membranes, suggested that these helices might contribute to positive 
membrane curvature induction and tubule formation. Unlike pVI and a peptide 
corresponding to the N-terminal amphipathic α-helix, the membrane lytic activity of 
6×His-tagged VIΔ54 does not appear to be as strongly influenced by the inclusion of 
lipids which alter the propensity for positive or negative membrane curvature (Maier and 
Wiethoff). Thus, it is possible that VIΔ54 is able to more strongly induce positive 
membrane curvature in the absence of lysolipids. Furthermore I determined that as seen 
with the amphipathic α-helix peptide, the 6×His-tagged VIΔ54 alone also cannot induce 
membrane tabulation. However my studies indicate that VI114Δ containing the 4 α-
helices generates tubular membrane structures (Maier and Wiethoff ; Maier, Galan et al. 
2010). Taken together these data suggest that although both the N-terminal amphipathic 
α-helix and VIΔ54 alone can induce positive membrane curvature, an intact VI114Δ 
membrane interacting domain is necessary to form membrane tubules. One possible 
explanation could be that an intact domain from residues 34–114 can stabilize the highly 
curved structures induced upon pVI membrane binding, either through cooperative 
influences on membrane curvature or through protein–protein interactions which would 
not occur in either the N-terminal peptide or VIΔ54 alone. Further studies are required to 
gain a better understanding of this phenomenon.  
Cooperativity between an N-terminal amphipathic α-helix which induces positive 
membrane curvature and additional helical domains which stabilize these curved 
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membranes is not unprecedented. A similar cooperativity is observed with the COPII 
proteins Sar1p, and scaffolding proteins Sec23/24p and Sec13/31p (Lee, Orci et al. 2005). 
During COPII vesicle formation an N-terminal amphipathic α-helix in Sar1p induces 
positive membrane curvature, which is then recognized and stabilized by the additional 
coat proteins Sec23/24p and Sec13/31p. The same is true for other proteins involved in 
membrane fission events such as those involving the N-BAR domain containing proteins, 
endophilin and amphiphysin (Masuda, Takeda et al. 2006; Low, Weininger et al. 2008). 
Topologically, membrane fission through induction of positive membrane curvature is 
very similar to the membrane fragmentation performed by Ad pVI. This similarity 
appears to be only conceptual, as pVI does not share any obvious sequence similarity 
with these proteins.  
Although the importance of membrane tubulation during Ad cell entry has yet to 
be defined, overexpression of the mRFP–pVI1–239 in mammalian cells was recently 
shown to result in the protein associating with dynamic tubular membrane structures 
(Wodrich, Henaff et al. 2010). Furthermore, studies with proteins which deform 
membranes have shown that the formation of tubular structures in vitro can be used as a 
marker for a protein's ability to mediate membrane fission in vivo (Lee, Orci et al. 2005). 
Therefore the cooperativity observed between the N-terminal amphipathic α-helix and the 
3 additional helices to form tubular structures in vitro might be important for pVI to 
fragment the endosomal membrane during cell entry. Further experiments will be 
required to define a role for these pVI domains in endosomal escape of Ad during cell 
entry.  
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As a whole, my data shed new light into the mechanisms of membrane disruption by a 
nonenveloped virus. Ads appear to possess a novel method for disrupting endosomal 
membranes during cell entry compared to those previously described for reoviruses, 
picornaviruses or parvoviruses. 
 
PROTEIN VI –MEMBRANE INTERACTIONS IMPORTANT FOR AD 
ENDOSOMAL ESCAPE 
 
Although my in vitro studies suggest that the N-terminal amphipathic α-helix is 
important for pVI lytic activity, the helix-lipid interactions necessary for Ad endosomal 
escape are not known.  Amphipathic α-helical peptides can bind membranes via two 
different interactions: hydrophobic and electrostatic (Dathe, Wieprecht et al. 1997; Dathe, 
Nikolenko et al. 2001). The protein VI amphipathic α-helix contains two Lys at positions 
45 and 52. Mutating these residues to the negatively charged Glu (K45E, K52E, 
K45EK52E) decreased pVI membrane binding and lytic activity. These data suggest that 
electrostatic interaction between the helix and membranes are important for pVI activity. 
Additionally, hydrophobic interactions are also important for this activity since mutating 
Trp residues to Ala (a residue with decreased hydrophobicity) (W37AW41A) greatly 
decreased pVI membrane binding and subsequent lysis.  
Work performed with antimicrobial peptides suggests that these two types of 
interactions are important for peptides that disrupt membranes though a detergent- like 
mechanism. An electrostatic interaction between basic residues in the peptide and the 
phospholipid head groups is needed for initial membrane binding. Hydrophobic residues 
binding the hydrophobic core of the lipid bilayer then generates a curvature stress in 
membranes resulting in fragmentation (Shai 1999). In addition to my study, these types 
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of interactions are also shown to be important for other nonenveloped viruses. The 
papillomavirus membrane disrupting peptide is located at the C terminus of the minor 
capsid protein L2 (Kamper, Day et al. 2006). This peptide contains hydrophobic and 
basic residues which are important for membrane binding and lytic activity. Reversing 
the positive charge of these residues or deleting hydrophobic residues decreases 
membrane binding and lysis (Kamper, Day et al. 2006). Although the high peptide 
concentration required for membrane disruption suggests that L2 functions via a 
detergent-like mechanism, the membrane lysis mechanism is not yet known. 
Together with collaborators we show that hydrophobic and electrostatic 
interactions between pVI amphipathic α-helix and membranes are also important for Ad 
endosomal escape. Using a random mutagenesis approach, our collaborators identified a 
Leu to Gln mutation at position 40 in pVI amphipathic α -helix that decrease virus 
infectivity and endosomal escape. I determined that a L40Q recombinant protein has 
decreased membrane binding and lytic activity. Taken together these data suggest that 
hydrophobic helix-membrane interactions are important for Ad endosomal escape 
(Moyer, Wiethoff et al.).  
Interestingly I found that in addition to decreased membrane affinity the L40Q 
mutant protein also has altered topology. At protein concentrations where lipid binding is 
saturated, I found that residues in the N terminus of the amphipathic α-helix are not 
interacting with membranes. These data suggest that membrane topology contributes to 
pVI lytic activity. However my data at this point do not distinguish between a defect in 
membrane affinity and membrane topology. To determine if the altered membrane 
topology contributes to the defect observed with L40Q, the membrane affinity of this 
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construct could be artificially enhanced using nickel chelating lipids ( DOGS-NTA-Ni) 
and a His tag on the protein. If a defect in membrane lytic activity is observed when 
L40Q affinity is similar to WT pVI, then I can conclude that the altered membrane 
topology contributes to the observed defect in lytic activity. 
At the same time, I found that a recombinant virus bearing the K45EK52E 
mutation also has a defect in endosomal escape. Electrostatic interactions between the 
amphipathic α-helix and membranes are therefore also important for Ad endosomal 
escape. Interestingly, viruses that have a single Lys mutated to Glu (K45E, K52E) do not 
have an entry defect, although these mutations do slightly decrease in vitro pVI 
membrane lytic activity. This discrepancy could be explained by the protein 
concentration present in our in vitro system (100nM) vs the endosomal compartment 
(~22mM). The increased pVI concentration in the endosome could therefore compensate 
for the slight decrease in pVI membrane lytic activity. 
 
  MEMBRANE FRAGMENTATION DURING AD ENTRY 
Although numerous studies indirectly document a membrane lytic event during 
nonenveloped virus entry, there has not been any direct evidence showing a virus 
transported across the disrupted limiting membrane. Since these studies are mainly done 
using fixed cells, one factor that contributes to the difficulty of capturing the lytic event is 
the speed at which virions cross the membrane. For example, electron microscopy studies 
of Ad infected cells have depicted virus at the cell surface, in an intact endosome or in the 
cytoplasm (Imelli, Ruzsics et al. 2009). Therefore, although my in vitro data indicate that 
Ad pVI fragments membranes, this process has not yet been documented during virus 
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entry. Work presented in this dissertation identifies galectin 3 (Gal-3) as a marker for 
disrupted endosomal membranes during Ad entry. Using this marker, together with our 
collaborators, we were able to see for the first time Ad endosomal escape in real time 
using live cell imaging. 
Gal-3 was first identified as a marker for vacuole lysis during bacterial infection 
(Paz, Sachse et al.). This cytosolic protein labels disrupted membranes by binding N-
linked glycans present on the exo-domains of membrane proteins when these are exposed 
to the cytoplasm following vacuole lysis. Similar to what was observed during bacterial 
phagosomal lysis, I found Gal-3 punctate structures in WT Ad infected cells but not in 
cells infected with a Ad2ts1, a mutant virus that fails to escape the endosome (Weber 
1976; Greber, Webster et al. 1996). Furthermore, these structures were not formed during 
infection with reovirus, a virus which forms size selective membrane pores (Agosto, 
Ivanovic et al. 2006). These data confirm our findings that Ad does not form size 
selective pores in membranes, and allows the passage of a 30kD Gal-3 protein from the 
cytosol to the lumen of the disrupted endosome. 
Identifying a marker for disrupted endosomal membranes allowed me to 
determine the fate of these membranes in the course of Ad infection.  Ad membrane 
disruption occurs only after the capsid partially disassembles and pVI is released from the 
capsid interior (Wiethoff, Wodrich et al. 2005) In line with these observations, using 
immunofluorescence microscopy I found that the Gal-3 structures only form after pVI is 
released from the capsid interior and can be detected using anti-pVI antibodies. 
Furthermore at 20 min post virus internalization, the majority of these structures contain 
both virus and pVI. These structures represent a virus that has recently lysed the 
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endosomal membrane. However as the virus moves towards the nucleus, later during 
infection, fewer Gal-3 structures contain virus. These observations suggest that the virus 
moves away from a disrupted endosome. 
Preliminary data from our lab suggests that after endosomal disruption pVI is 
degraded by an unknown mechanism. My studies confirm these findings, as I observed a 
decrease in the number of pVI puncta by 4 hrs post virus internalization. The same trend 
is observed for the number of Gal-3 structures as well. Furthermore although the total 
number of Gal-3 structures decreased with time, the percentage of Gal-3 that colocalizes 
with pVI remains the same. These data further confirm that Gal-3 labels pVI disrupted 
endosomal membranes during Ad entry, and these membranes are degraded by an 
unknown mechanism.  
Dupont et al. proposed that phagocytic membrane fragments labeled with Gal-3 
are degraded by autophagy. This group showed that during Shigella infection, proteins on 
ruptured phagosomal membrane are ubiquitinated. Ubiquitinated proteins then recruit the 
autophagy marker LC3 and are targeted to autophagic degradation (Dupont, Lacas-
Gervais et al. 2009). Recently data from our lab suggest that LC3 is recruited to Gal-3 
positive membranes during Ad infection, suggesting that these membrane remnants might 
also be degraded by autophagy.  Further studies need to be performed to determine how 
pVI and Gal-3 positive membranes are being degraded.  
Since disrupted endosomes can be labeled with Gal-3, Ad endosomal escape 
could be visualized in real time. Until now this process has been measured as the 
translocation of membrane impermeable toxins (Moyer, Wiethoff et al. ; Wiethoff, 
Wodrich et al. 2005; Wodrich, Henaff et al. 2010) and antibody–toxin conjugates 
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(FitzGerald, Padmanabhan et al. 1983) across the endosomal membrane. By infecting 
cells overexpressing RFP-Gal-3 with a fluorescently labeled virus, our collaborators 
visualized Ad escaping a Gal-3 positive disrupted endosome. Additionally, they found 
Gal-3 structures forming around the virus, indicative of a virus that just lysed the 
endosomal membrane. Visualizing Ad endosomal escape in real time allowed us to make 
an observation that could not be made in fixed cells. We observed that Ad seems to 
struggle to escape the endosome. A delay in this process could be in part explained by a 
need for additional factors to be recruited to the endosomal membrane. 
One factor that might be important for Ad endosomal escape is pVI interaction 
with microtubules. Studies have shown that many cellular organelles use microtubule 
movement to generate or maintain their structure. One such example is the extension of 
tubular structures from the ER (Terasaki, Chen et al. 1986; Lee and Chen 1988). 
Microtubule motors are thought to bind integral membrane proteins in this organelle, and 
the actual movement on microtubules is thought to drive tubule formation (Allan and 
Vale 1994) Tubule formation is indicative of membrane curvature stress, which in the 
case of pVI ultimately results in membrane lysis (Maier, Galan et al. 2010). Protein VI 
was shown to travel on microtubules (Wodrich, Henaff et al. 2010). Furthermore, 
preliminary data from our lab suggests that a virus with a mutation in pVI that decreases 
microtubule movement is less efficient at endosomal escape. This mutant virus 
colocalizes with Gal-3 structures longer then WT virus, suggesting that it takes longer for 
this virus to escape the endosome. Our collaborators confirmed these findings by live cell 
microscopy. Therefore pVI movement on microtubule might enhance the initial 
membrane curvature stress induced by pVI leading to membrane disruption. Another 
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possibility is that pVI initiates this process, and interaction with microtubules motors 
allows for the endosomal membrane to be “peeled” away, allowing the virus to escape. 
However, the role of pVI microtubule movement in endosomal escape is not yet known. 
The membrane curvature induced by pVI could also be enhanced by a family of proteins 
known as the sorting nexins (SNX). These are cytosolic proteins that bind membranes 
either through protein-protein interactions, or through a lipid binding motif. SNX are 
involved in protein sorting and regulation of vesicle trafficking  (Worby and Dixon 
2002). One of the membrane binding motifs found in SNX is a bin-amphiphysin-RVS 
(BAR) domain (Pylypenko, Lundmark et al. 2007; Shin, Ahn et al. 2008). This α-helical 
domain has a concave shape, and has been shown to sense as well as induce membrane 
curvature (Habermann 2004) Our collaborators have observed that when overexpressed 
in cells, pVI colocalizes with SNX 1/2, although the significance of this colocalization 
has not been documented. However it is possible that pVI initiates endosomal lysis by 
inducing membrane curvature which is then recognized by the BAR domain of SNX.  In 
support of this observation, in vitro studies in our lab with purified pVI and the BAR-
domain of SNX1 show that pVI fragmentation of liposomal membranes increases the 
amount of membrane-associated BAR-domain.   Thus, these BAR-domain containing  
proteins could be recruited to the endosomal membrane and enhance membrane curvature 
which could help fragment endosomal membranes and release virus into the cytoplasm. 
Further investigation is required to determine if SNX play a role in Ad endosomal escape. 
The data presented in this dissertation supports a gross reorganization of the endosomal 
membrane by pVI. However the extent of membrane fragmentation is still not known. 
Using Gal-3 as a marker for disrupted endosomal membranes, immuno-electron 
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microscopy could be performed and these membrane fragments could be visualized.  This 
would be the first time that membrane fragments would be observed during entry of a 
nonenveloped virus. 
 
THE ROLE OF POSITIVE MEMBRANE CURVATURE IN AD ENDOSOMAL 
ESCAPE 
 
The recruitment of additional factors to the endosomal membrane could explain 
the need for pVI induced positive membrane curvature induction during Ad endosomal 
escape.  My in vitro studies as well as others in the lab suggest that pVI induces positive 
membrane curvature (Maier, Galan et al. 2010). Furthermore, the N terminal amphipathic 
α-helix membrane topology dictates the type of curvature induced by pVI. A series of 
recombinant pVI constructs with mutations in the amphipathic α-helix that should either 
alter the depth of membrane penetration (S1L/T1L), or the angle of membrane insertion 
(S1I/G3I/F12S), are defective in positive curvature induction. An important question that 
remains unanswered then is whether viruses bearing these mutations are defective in 
endosomal escape. Answering this question would help us understand the significance of 
pVI induced positive membrane curvature during Ad infection.  
Membrane curvature stress is relieved by a distortion of the membrane shape, 
forming highly curved membranes. BAR domain containing proteins, such as SNX 
described earlier, sense and bind these membranes, further enhancing membrane 
curvature (Worby and Dixon 2002). An excess amount of curvature strain then fragments 
membranes by the detachment of patches from the membrane surface. Therefore pVI 
induced positive membrane curvature can either be important for membrane 
fragmentation or for recruiting additional proteins to the endosomal membrane.  
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While we determined that Ad pVI fragments membranes by inducing positive membrane 
curvature, studies with peptides that produce negative membrane curvature have shown 
that these can also lyse membranes. Influenza hemagglutinin fusion peptide induces 
negative membrane curvature, and at certain concentrations it can facilitate the release of 
fluorescent dyes from liposomal membrane (Epand, Macosko et al. 1999). Furthermore, 
the cell toxicity of certain amyloidogenic peptides is dependent on their ability to 
fragment membranes by inducing negative membrane curvature strain (Smith, Brender et 
al. 2009).  Thus, it is interesting to consider whether Ad pVI fragmentation of membranes 
through induction of positive vs negative membrane curvature is important for virus cell 
entry.   
It is interesting to speculate, based on preliminary studies described earlier, that 
additional cellular or viral proteins might be important for Ad endosomal escape. It may 
be possible that the positively curved membranes generated by pVI are recognized by 
these proteins. Future studies using viruses that bearing the mutations described above 
could determine what role pVI positive membrane curvature induction plays in Ad 
endosomal escape. 
 
ADENOVIRUS MEMBRANE FRAGMENTATION ACTIVATES THE 
INNATE IMMUNE RESPONSE 
 
In addition to mediating Ad endosomal escape, pVI membrane lysis can also 
contribute to Ad-induced proinflammatory response. Ads have numerous qualities that 
make them excellent vectors for gene therapy, however their use has been greatly limited 
by the potent inflammatory response generated upon systemic administration  (Volpers 
and Kochanek 2004).  Activation of the immune response results in rapid Ad vector 
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elimination, as well as tissue damage (Worgall, Leopold et al. 1997; Muruve, Barnes et 
al. 1999). This response is dominated by infected macrophages secreting the 
proinflammatory cytokine IL1β (Shayakhmetov, Li et al. 2005). Recent studies 
demonstrate that macrophages are stimulated by Ad to secrete this cytokine by activating 
a multi-protein complex called the Nalp3 inflammasome (Muruve, Petrilli et al. 2008).  
Ad inflammasome activation is in part mediated by pVI membrane lytic activity, and 
requires release of endosomal cathepsins (Barlan, Griffin et al. 2010). Interestingly, 
reovirus, a nonenveloped virus that also escapes from the endo-lysosomal compartment, 
does not facilitate cathepsin B release or activation of the Nalp3 inflammasome (Barlan, 
Danthi et al.). As mentioned earlier, reovirus disrupts membranes by forming size 
selective pores (Agosto, Ivanovic et al. 2006). The 28kD cathepsin B is not able to escape 
through these pores, but it can escape following the gross membrane reorganization 
induced by pVI.  
Furthermore, the membrane fragments that are potentially generated during Ad 
endosomal escape can also serve as a danger signal that can activate the immune 
response. Phagosomal membrane remnants during Shigella infection act as danger 
associated molecular patterns that activate different components of the innate immune 
system (Dupont, Lacas-Gervais et al. 2009). Therefore the mechanism used by pVI to 
disrupt membranes contributes to innate immune activation. Elucidating the mechanism 
used by Ad to escape endosomes has therefore led not only to a better understanding of 
nonenveloped virus membrane penetration, but how this process stimulates an immune 
response. 
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